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credibility of the WHO guideline has not been challenged 
by new studies.
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Introduction
Formaldehyde (FA; 1 ppm = 1.23 mg/m3 at 1 atm and 
25 °C) is a high-volume chemical, which is used for dis-
infection purposes and as a preservative. Also, it is used 
in the production of resins and binders, which are used in 
wood-products (e.g. particle board and plywood), pulp and 
paper, and mineral wool. Furthermore, FA is used in the 
production of plastics, coatings and paints, flooring materi-
als, for textile finishing, for synthesis of chemicals, and it 
is a component of combustion products (Salthammer et al. 
2010; IARC 2012). Additionally, FA is a major compound 
derived from ozone-initiated reactions with alkenes, e.g. 
terpenes (Atkinson and Arey 2003). Due to its ubiquitous 
use, FA is a common indoor air pollutant.
The majority of the studies showed that indoor air con-
centrations in Europe and the USA were below 100 µg/m3 
and the median, geometric mean or arithmetic means 
ranged between 5 and 60 µg/m3 (Salthammer et al. 2010; 
Sarigiannis et al. 2011). Overall, these levels are supported 
by recent studies in industrialized countries. Thus, nurs-
ing homes for elderly people in seven countries in Europa 
had a mean (8 h) FA concentration of 7 µg/m3 and a maxi-
mum concentration of 21 µg/m3 (Bentayeb et al. 2015). In 
a study in French dwellings, the range of FA concentrations 
varied from 18 to 26 µg/m3 (Brown et al. 2015). In another 
study in French dwellings, the mean, 90th percentile and 
the maximum concentration was 29, 46 and 113 µg/m3, 
Abstract In 2010, the World Health Organization (WHO) 
established an indoor air quality guideline for short- and 
long-term exposures to formaldehyde (FA) of 0.1 mg/
m3 (0.08 ppm) for all 30-min periods at lifelong expo-
sure. This guideline was supported by studies from 2010 
to 2013. Since 2013, new key studies have been published 
and key cancer cohorts have been updated, which we have 
evaluated and compared with the WHO guideline. FA is 
genotoxic, causing DNA adduct formation, and has a clas-
togenic effect; exposure–response relationships were non-
linear. Relevant genetic polymorphisms were not identified. 
Normal indoor air FA concentrations do not pass beyond 
the respiratory epithelium, and therefore FA’s direct effects 
are limited to portal-of-entry effects. However, systemic 
effects have been observed in rats and mice, which may 
be due to secondary effects as airway inflammation and 
(sensory) irritation of eyes and the upper airways, which 
inter alia decreases respiratory ventilation. Both secondary 
effects are prevented at the guideline level. Nasopharyn-
geal cancer and leukaemia were observed inconsistently 
among studies; new updates of the US National Cancer 
Institute (NCI) cohort confirmed that the relative risk was 
not increased with mean FA exposures below 1 ppm and 
peak exposures below 4 ppm. Hodgkin’s lymphoma, not 
observed in the other studies reviewed and not considered 
FA dependent, was increased in the NCI cohort at a mean 
concentration ≥0.6 mg/m3 and at peak exposures ≥2.5 mg/
m3; both levels are above the WHO guideline. Overall, the 
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respectively, in children’s bedrooms (Dallongeville et al. 
2015). Another study compared apartments in Finland and 
in Lithuania (Du et al. 2015). The mean and maximum 
concentrations were 17.5 and 40 µg/m3 and 23 and 51 µg/
m3, respectively. A Spanish study showed that homes in a 
Spanish city had a mean, 75th percentile and maximum FA 
concentration of 55, 74 and 91 µg/m3, respectively (Vil-
lanueva et al. 2015). In another Spanish study, no differ-
ence was found in FA concentrations in indoor air concen-
trations in the bedrooms, living rooms and non-industrial 
workplaces, mainly offices, where the mean concentration 
was about 25 µg/m3 and ranged from 6 to 48 µg/m3 (Rovira 
et al. 2016). Mullen et al. (2016) showed that in Californian 
homes, the 25th and 75th percentiles were 12 and 25 µg/
m3, respectively, with a maximum of 50 µg/m3. In another 
Californian study, the mean FA concentration was 34 µg/m3 
in homes built with low-emitting materials and 46 µg/m3 
in conventional homes at an air exchange rate of 0.35 h−1 
(Hult et al. 2015). Furthermore, 40 early childhood edu-
cation facilities were studied in California; the arithmetic 
mean FA concentration was 19 µg/m3 with a range from 0.7 
to 49 µg/m3 (Bradman et al. 2016). In houses inhabited by 
asthmatics in the Boston area, the geometric mean FA con-
centration was 43 µg/m3. The concentrations ranged from 6 
to 162 µg/m3, and 6 % of the houses had a FA concentration 
exceeding 122 µg/m3 (Dannemiller et al. 2013). In homes 
in Australia, the mean and maximum FA concentration was 
15 and 46 µg/m3, respectively (Lazenby et al. 2012). In 
homes in Japan, the mean and maximum concentration was 
13 and 58 µg/m3, respectively, in the winter and in the sum-
mer 34 and 220 µg/m3, respectively, with 0.7 % exceed-
ing 100 µg/m3 (Uchiyama et al. 2015). In Korea, in newly 
built apartments at the pre-occupancy stage, the mean, the 
95th percentile and the maximum FA concentration was 
61, 110 and 160 µg/m3, respectively (Shin and Jo 2012). In 
apartments in a Chinese city, the mean (range) concentra-
tion was 100 (80–130) µg/m3 in living rooms (Zhu and Liu 
2014). In Beijing, even higher concentrations were found 
in dwellings and offices that had been remodelled within 
the past year. Thus, the mean (±SD) was 131 ± 90 µg/m3 
in dwellings with a maximum concentration of 800 and 
85 ± 56 µg/m3 in offices with a maximum concentration of 
300 µg/m3 (Huang et al. 2013).
Many countries have set guideline values for indoor air 
FA (Salthammer et al. 2010). The World Health Organiza-
tion (2010) set an indoor air quality guideline (IAQG) for 
FA at 0.1 mg/m3 (0.08 ppm), which applies to all 30-min 
periods lifelong. The guideline was further supported by 
extended literature reviews (Nielsen and Wolkoff 2010; 
Wolkoff and Nielsen 2010). Shortly after the WHO pre-
sented its recommendation, Golden (2011) also analysed 
the FA data and proposed an indoor air guideline value of 
0.1 ppm (0.12 mg/m3). A recent update by IARC (2012) 
classified FA as “carcinogenic to humans (Group 1)” on 
the basis that FA may cause cancer of the nasopharynx and 
leukaemia, whereas there was limited evidence for associa-
tion with sinonasal cancer. However, a consistent finding is 
the observed occurrence of nasal cancer in rats and mice at 
high FA exposures.
Many new key studies have been published that have 
been used in this re-evaluation of the WHO (2010) IAQG. 
Previous conclusions have been summarized from the eval-
uations (WHO 2010; Nielsen and Wolkoff 2010; Wolkoff 
and Nielsen 2010; Golden 2011; RAC 2012; Nielsen et al. 
2013; NRC 2014). The focus of this review is recent stud-
ies (mainly years ≥ 2013); however, for transparency rea-
sons, earlier key studies have also been included when con-
sidered appropriate. We have excluded new occupational 
studies that do not include measured FA concentrations, 
studies where the exposure–response relationships could 
not be evaluated (e.g. Attia et al. 2014; Santovito et al. 
2014), and studies with complex environmental exposures 
(e.g. Vilavert et al. 2014) where no measured health effect 
was included or where a low-level environmental FA expo-
sure was a proxy of an exposure to a complex outdoor air 
mixture (e.g. Marcon et al. 2014) as such exposures do not 
allow disentangling of the effects of FA. It should be noted 
that this does not mean that such studies are not useful for 
risk management purposes. Also, we excluded animal stud-
ies with mixtures where effects of FA could not be disen-
tangled (e.g. Wang et al. 2013a) and studies with exposures 
to FA aerosols (e.g. Lima et al. 2015) as the WHO IAQG 
is set for gaseous FA. Although the specific purpose is the 
evaluation of the WHO IAQG for FA, the evaluated studies 
are also relevant for setting other guidelines or standards 
for FA, for example, occupational exposure limits.
Absorption, distribution, metabolism 
and elimination
Due to its high water solubility and reactivity, airborne FA 
is absorbed mainly (~90 %) in the upper airways (c.f. WHO 
2010; Nielsen et al. 2013). In the aqueous tissue phase, 
FA adds water, forming methandiol (methylene glycol, 
CH2(OH)2), accounting for more than 99.9 % of total FA 
in the aqueous phase. CH2(OH)2 is in equilibrium with free 
FA (<0.1 %) in the water phase, where CH2(OH)2 serves 
as a FA liberator. CH2(OH)2 itself may have a low toxic-
ity (Golden and Valantini 2014). In the tissue, FA forms 
adducts and cross-links with RNA, DNA and proteins, 
including DNA–protein cross-links (DPX). In rat nasal tis-
sue, DPX increases disproportionately at exposure levels 
above 2–3 ppm. FA is an endogenous metabolite, and its 
blood concentration is about 2–3 mg FA/L. The half-life 
of FA in blood is about 1–1.5 min. FA is metabolized to 
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formate, which is incorporated in tissue components via 
the one-carbon pool, excreted in the urine or oxidized to 
carbon dioxide (c.f. WHO 2010; Nielsen et al. 2013). 
Using a specific (unbiased) method, the FA concentration 
in air exhaled through the mouth was found at levels up to 
1.7 ppb; this figure may be higher shortly after smoking a 
cigarette. However, the concentration was below 0.5 ppb in 
most cases (Riess et al. 2010). The exhaled FA concentra-
tion may be higher in air breathed through the nose (Spanel 
et al. 2013). Estimated FA deposition in the upper airways 
and DPX formation were similar in children and adults 
(c.f. WHO 2010; Nielsen and Wolkoff 2010; Nielsen et al. 
2013).
Uptake of FA in the nose of rats, monkeys and humans 
was estimated by means of an anatomically accurate com-
putational fluid dynamics model. At ≥0.1 ppm, the nasal 
uptake was about 99, 87 and 85 %, respectively. The 
uptake was nonlinear, especially at lower concentrations 
(<0.1 ppm), and thus resulted in a lower nasal uptake frac-
tion due to the effects of endogenous FA. Also, the higher 
fluxes were predicted to occur in regions located in the 
more anterior sections of the nose (Schroeter et al. 2014).
A mechanistic model was developed to study the 
uptake of airborne FA and transport into the surrounding 
lung tissue at 1 mg/m3 in humans. Disregarding the scrub-
bing effects of the nasal and oral tissue, it was predicted 
that FA would be quickly absorbed (~97 %) by the mucus 
membranes with a very high uptake in the trachea (airway 
generation 0), and that no FA would pass beyond airway 
generation 8. Thus, no FA would reach the deep airways, 
including the alveoli, and no FA was predicted to pass to 
the blood compartment (Asgharian et al. 2012).
In the mucus layer, CH2(OH)2 diffuses into the epithe-
lial cells and liberates FA, which reacts with glutathione 
(GSH), proteins, DNA and RNA. The GSH adduct (GS-
FA) is oxidized by the FA dehydrogenase to the formate 
adduct. After hydrolysis, GSH and formate are released. 
Rats were exposed to 0 (control), 0.7, 2, 6, 10 and 15 ppm 
FA 6 h/day for 1, 4 or 13 weeks. Nasal tissue concentra-
tions of CH2(OH)2, GSH, GS-FA and DPX were assessed 
as were histological effects, epithelial cell proliferation 
and gene expression. The data were analysed by means of 
a pharmacokinetic model, taking into account the back-
ground CH2(OH)2 and GSH levels. The cellular levels of 
CH2(OH)2 and DPX only showed a minor increase with 
exposures at 0.7 and 2 ppm FA. At these levels, GSH 
decreased slightly. Several ppm FA would be required to 
achieve significant changes. Above 4 ppm, the changes 
were more conspicuous. Histopathology showed nasal 
lesions at 2 ppm and epithelial cell proliferation at higher 
concentrations. The lowest benchmark dose for change of 
gene expression approximated 1 ppm. The authors con-
cluded that genomic changes at 0.7–2 ppm likely reflected 
changes in extracellular CH2(OH)2 and GSH levels and that 
FA levels below 1 or 2 ppm would not affect FA homeosta-
sis within the epithelial cells (Andersen et al. 2010).
A major advance was the differentiation between FA-
induced DNA damage from the (normal) endogenous FA 
(CH2O) level in blood and tissue and from the inhaled 
(exogenous) FA, using isotope-labelled FA (13CD2O) for 
the airborne exposure; exposure in rats was to 10 ppm 
labelled FA for 1 or 5 days at 6 h/day. Inhaled FA induced 
labelled mono-adducts (N2–HO–13CD2-deoxyguanosine; 
labelled FA-dG), DNA–13CD2–DNA cross-links (labelled 
dG–FA–dG) and labelled DPX in the nasal tissue. Both at 1 
or 5 days of exposure, the labelled FA-dG adduct was about 
10 times more common than labelled dG–CH2–dG in the 
nasal tissue. The labelled FA-dG adduct on day 1 and day 
5 was 32 and 46 %, respectively, and labelled dG–FA–dG 
was 45 and 59 %, respectively, of the respective adduct 
type. Neither labelled FA–dG nor labelled dG–FA–dG was 
detected in the liver, lungs, thymus, bone marrow, spleen 
and the blood lymphocytes. In contrast, high amounts of 
endogenous FA adducts were detected in all tissues. This 
indicated that exogenous FA exposures only had access to 
the portal-of-entry area (Lu et al. 2010). The dominating 
FA adduct to DNA is the FA–dG, which can be used as a 
sensitive biomarker of FA exposure (Lu et al. 2012a).
A single 6-h exposure to 0.7, 2, 6, 9 or 15 ppm in rats 
showed that the ratio between exogenous FA–dG and 
endogenous FA–dG was 0.01, 0.03, 0.2, 0.6 and 2.8, 
respectively, indicating a strongly nonlinear relationship in 
the nasal tissue. No exogenous FA–dG adduct was found 
in the bone marrow at the 15-ppm exposure concentration 
(Lu et al. 2011). Also in monkeys exposed to 2 or 6 ppm, 
6 h/day for 2 days, the external FA–dG adduct was only 
detected in the nose and not in the bone marrow. At 6 ppm, 
the FA–dG adduct level was lower in the monkeys than in 
rats with a single 6-h exposure, suggesting a lower geno-
toxic effect in primates than in rats (Moeller et al. 2011).
FA is a major source of N6-formyllysine (FA-Lys) 
adducts in cell proteins. In rats, exposure to isotope-
labelled FA (13CD2O) at 0.7, 2, 6 and 9 ppm for 6 h was 
used to differentiate between adducts from exogenous and 
endogenous FA-Lys adducts in the total amount, the cyto-
plasmic, the membrane and the nuclear proteins. After pro-
teolysis and analysis of FA-Lys, the ratio between exoge-
nous and endogenous adducts was shown to increase with 
increasing exposures; for example, for the total amount 
nasal epithelial proteins, the ratio was 0.035, 0.14, 0.15 
and 0.40, respectively. At each FA exposure, the ratios 
were in the order cytoplasmic ≈ membrane > soluble 
nuclear > chromatin protein bound, indicating a decrease 
in the exogenous FA concentration from the cytoplasmic 
to the nuclear proteins. In contrast, the endogenous FA-Lys 
adducts were similar at all exposure concentrations in all 
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cellular compartments. Moreover, this indicated that the 
exogenous FA exposure did not influence the endogenous 
FA production. No external FA-Lys adducts were detected 
in the lungs, liver and bone marrow, and thus the results 
paralleled studies on FA-dG adducts, confirming that direct 
exogenous FA effects are limited to the nasal epithelium 
(Edrissi et al. 2013).
In rats, absorption of inhaled FA into the blood was 
studied with (13C) labelled FA for a single 6-h exposure to 
10 ppm; this allows differentiation between endogenous FA 
and FA from external exposure. The background blood FA 
levels were from 1.9 to 5.4 mg/L. Inhalation of FA did not 
increase the blood FA level nor was inhaled (13C labelled) 
FA detected in the blood above the natural background 
level (Kleinnijenhuis et al. 2013). These findings provide 
further support for the finding that the airway epithelium in 
rats is an efficient barrier against even high FA concentra-
tion and its transport into the blood.
In a recent rat study, the exposure period was extended 
to 28 days with 2 ppm (13CD2)-labelled FA for 6 h per day 
and 7 days per week. Exogenous and endogenous FA–
DNA adducts were obtained from the labelled and unla-
belled FA–dG biomarker. The biomarker was considered 
to represent both mono-adducts and DPX-adducts as the 
DPX cross-links hydrolysed spontaneously to the mono-
adduct. The exogenous adduct accumulated during the 
28-day period and reached quasi-steady state after 28 days, 
at which point the ratio between the exogenous and endog-
enous adducts was 0.37 in the nasal tissue; this value was 
higher than the ratio after a few exposures. In the first 6 h 
post-exposure, there was a rapid initial loss of nearly 20 % 
of the adducts in the nasal tissue that was followed by a 
phase with a longer half-life of 7.1 days. This was consid-
ered to reflect DNA repair and/or spontaneous hydrolysis. 
No consistent exogenous adducts were found in internal 
organs, including the white blood cells, trachea, tracheal 
bronchial lymph nodes and lungs. This is in agreement 
with results from previous studies with fewer exposures 
conducted by the research group. Also, monkeys (cynomol-
gus macques) were exposed to 13CD2-FA at 6 ppm for 6 h 
per day for 2 days. The exogenous biomarker was only 
observed in the nasal tissue and not in the tracheal carina, 
proximal trachea, white blood cells and the bone marrow 
(Yu et al. 2015).
Furthermore, DPX formation has been studied by an 
ultrasensitive and selective liquid chromatography-mass 
spectrometry method, where monkeys and rats were 
exposed to (13CD2)-labelled FA. This allowed differentia-
tion between DPX from inhaled FA and DPX from endog-
enous (normal) FA. Monkeys were exposed at 6 ppm, 6 h 
per day for 2 days. Labelled DPX was detected in the nasal 
tissue, but not in the peripheral blood mononuclear cells, 
bone marrow and the liver. Endogenously generated DPX 
was detected in all investigated tissues. In the nasal tis-
sue, endogenous DPX was about threefold higher than the 
exogenously generated DPX. Different tissues had differ-
ent endogenous DPX levels. Thus, endogenous DPX was 
almost threefold higher in the liver than in the nasal tissue. 
Rats were exposed at 15 ppm, 6 h per day up to 4 days. 
Also in rats, exogenous DPX was only detected in the 
nasal tissue. Furthermore, the decay of exogenous DPX 
was studied in rats, which were exposed at 2 ppm, 6 h per 
day for 7 and 28 days, respectively, with a post-exposure 
period up to 7 days. In the post-exposure period, the exog-
enous DPX decreased slowly (~10 %). In the nasal tissue, 
exogenous DPX increased with the number of exposures in 
both rat studies (Lai et al. 2016). It is noted that inhaled FA 
only caused DPX formation in the nasal tissue and DPX 
formation in internal organs cannot be explained by a direct 
transport of FA to the internal organs.
Overall, the recent studies have demonstrated that air-
borne FA does not reach internal organs. Thus, if systemic 
effects occur, they have to be explained by secondary 
effects from portal-of-entry toxicity, which includes sen-
sory-irritation-induced hypoxia (Nielsen et al. 2013) and 
airway inflammation. Other important findings are that the 
recent studies confirm that the external-induced FA-DNA 
adducts increase disproportionately in the nasal tissue at 
high FA concentrations that is similar to the exposure–
response relationship for nasal cancer in rats. Furthermore, 
rats had more exogenous induced DNA adducts in the nasal 
tissue than monkeys.
The WHO (2010) IAQG accepts that direct internal 
organ effects may occur if the metabolic capacity of the 
upper airways is overloaded; this may begin at ≥2 ppm. 
Overall, the WHO (2010) evaluation constitutes a conserv-
ative approach.
Genotoxicity
Formaldehyde is genotoxic due to its covalent binding to 
DNA, causing DNA mono-adducts, DNA–DNA cross-
links, DPX and DNA glutathione cross-links that can 
cause mutations and clastogenic effects such as DNA 
strand breaks, chromosomal aberration (CA), micronu-
cleus (MN) formation and sister chromatid exchange 
(SCE) as reviewed (IARC 2006; RAC 2012; NRC 2014; 
Kawanishi et al. 2014; Yu et al. 2015). Repair of the FA–
DNA mono-adducts may include the base excision repair 
(BER) pathway, and the intra-strand cross-links may be by 
the nucleotide excision repair (NER) pathway (Kawanishi 
et al. 2014). FA-induced DPX may be repaired by the NER 
repair and by the homologous recombination (HR) path-
ways (de Graaf et al. 2009; Kawanishi et al. 2014; McHale 
et al. 2014). Furthermore, DPX may partly be broken 
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down by specific proteolytic enzymes, allowing transle-
sion synthesis polymerases (a potentially mutagenic path-
way) to replicate across DNA-peptide lesions. Addition-
ally, a tolerance pathway also exists, allowing replication 
across unrepaired DPX lesions that may include strand 
breaks (potentially causing genomic rearrangements) fol-
lowed by strand ligation (Stingele et al. 2015). Not least, 
the Fanconi anaemia pathway is important in the repair of 
inter-strand DNA cross-links and DPX (Ren et al. 2013; 
Kirsch-Volders et al. 2014; McHale et al. 2014; Schneider 
et al. 2015).
Endogenously generated FA and toxicity
As FA is an endogenously generated compound, it may 
play a role in induction of diseases. Thus, a recent experi-
mental study showed that elevation of the endogenous 
(natural) FA concentration in tissues can cause cell dam-
age and destruction, as well as genetic damage and can-
cer (Pontel et al. 2015). As FA is detoxified to formate by 
the alcohol dehydrogenase 5 (ADH5), mice without the 
gene (Aldh5−/−) had elevated FA-dG adducts in the bone 
marrow (1.7-fold), kidney (1.7-fold) and liver (2.3-fold) 
compared with the wild-type (Ald5+/+) mice. In Aldh5−/− 
mice, administration of methanol [a FA precursor (Lu et al. 
2012b)] further increased the level of FA–dG adducts. As 
the FANCD2 protein is involved in the repair of FA–DNA 
cross-links, Fancd2−/− mice were also studied. The double 
deletion (Aldh5−/− Fancd2−/−) caused a profound decrease 
in survival, induced blood pancytopenia, reduced bone 
marrow cellularity (including hematopoietic stem and 
progenitor cells) and colony formation at cultivation of 
spleen hematopoietic stem cells. Cultivated spleen B cells 
stimulated with lipopolysaccharide showed a high level 
of chromosome breakages. Additionally, liver and kid-
ney dysfunction with DNA damages were also observed. 
In contrast, no or limited effects were observed on the 
mentioned endpoints in the wild-type mice or mice with 
a single deletion of Aldh5−/− or Fancd2−/−, indicating a 
profound synergistic interaction between deletion of both 
the Aldh5−/− and Fancd2−/− genes. Transplantation of 
bone marrow from the wild-type mice to the double-defi-
cient (Aldh5−/− Fancd2−/−) mice increased survival time 
and decreased kidney toxicity, but these animals devel-
oped hepatocellular- and cholangiocarcinoma as well as 
T-lymphoblastic leukaemia. The authors concluded that 
FA is an important source of endogenous DNA damage 
that is counteracted in mammals by conserved protection 
mechanisms. It is noted that FA can cause serious damage 
at the place of contact. However, to observe these effects, 
external FA has to reach the blood and afterwards the 
internal organs, and this has not been observed in compre-
hensive toxicokinetic studies.
Genotoxicity in human epithelial and blood cells
Previous reviews have shown that occupational exposures, 
either to mean or to peak FA concentrations from about 
1 ppm and above, were associated with single strand break, 
MN formation, SCE and chromosomal aberration in buc-
cal and nasal epithelial cells, and in peripheral lymphocytes 
(Nielsen and Wolkoff 2010; Nielsen et al. 2013). This indi-
cates that an IAQG has to be below 1 ppm.
Ladeira et al. (2013) studied genotoxicity in buccal 
mucosa cells and showed an increase in MN frequency in 
employees exposed to FA in six histopathology hospital 
laboratories in Portugal; mean exposure for 8-h periods 
was 0.16 ppm (range 0.04–0.51 ppm) with a mean peak 
exposure of 1.14 ppm (range 0.18–2.93 ppm). The buc-
cal MN effect may be a high-level effect. This finding 
was supported by a previous study with exposure for 4 h 
per day for 10 working days, where the daily background 
(constant) FA exposures ranged from 0.15 to 0.5 ppm with 
added peak exposures up to 1 ppm. At these exposure lev-
els, no increase was observed in buccal MN compared to 
the pre-exposure MN level (Speit et al. 2007). Similarly in 
a controlled chamber study with FA exposure for 4 h for 
5 days, where the FA concentrations ranged from 0.3 to 
0.7 ppm with peaks up to 0.8 ppm, FA exposure had no 
effect on MN occurrence in the nasal epithelium (Zeller 
et al. 2011).
The recent studies on genotoxic effects in blood lym-
phocytes are listed in Table 1. Studies in pathology lab-
oratories confirm the previous association between FA 
exposure and genotoxicity in lymphocytes, where expo-
sures included mean FA concentrations or peak concen-
trations above 1 ppm. Where peak exposures were not 
reported, it can reasonably be assumed that exposures 
included peak concentrations above 1 ppm, as suggested 
from the studies where peak exposures were measured 
and in agreement with previous evaluations (Nielsen and 
Wolkoff 2010; Nielsen et al. 2013). Furthermore, this is 
supported by a study in pathology laboratory workers, 
who were exposed during successive decanting opera-
tions, where they manually emptied and filled tissue 
processor reagent reservoirs (Persoons et al. 2012). The 
measured 15-min average concentration was 1.17 mg/
m3 (1.0 ppm), whereas the estimated concentration was 
1.7 mg/m3 (1.4 ppm), and the upper 95th percentile was 
4.32 mg/m3 (3.5 ppm). The mean instantaneous peak con-
centration was 19.5 mg/m3 (16 ppm), and the upper 95th 
percentile was 43.4 mg/m3 (35 ppm). In another study, 
plywood workers had exposures to high mean concentra-
tions (Lin et al. 2013), and the peak concentrations may 
reasonably have been considerably higher than the mean 
concentrations. In contrast, workers in a medium density 
fibreboard plant (Aydin et al. 2013) had a stable exposure 
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concentration as the mean and the peak concentrations 
were of the same order of magnitude (≤0.3 ppm). How-
ever, the interpretation of the study by Aydin et al. (2013) 
is complicated by the fact that 57 % of the workers used 
dust masks, suggesting a considerable and unmeasured 
dust concentration. It is also noted that positive comet 
assay tests with increased DNA migration were observed 
in some studies (Lin et al. 2013; Costa et al. 2015), which 
is difficult to reconcile with a direct FA effect as FA 
should induce DPX, causing a decrease in DNA migration 
(e.g. Speit et al. 2009).
A cross-sectional study was performed in 43 FA-exposed 
workers and 51 matched controls (Zhang et al. 2010). The 
8-h time-weighted average (TWA) FA concentration was 
1.28 (10th, 90th percentile: 0.63, 2.51) and 0.026 (0.009, 
0.026) ppm, respectively. The FA-exposed workers had 
a significantly lower white and red blood cell, lympho-
cyte, granulocyte and platelet count, but not of monocyte 
count. Blood mononuclear cells were cultivated to granu-
locyte–macrophage colony-forming progenitor (CFU-GM) 
cells, which were 20 % lower in the FA-exposed workers. 
However, this was not statistically significant (p = 0.10). 
A small subset of 10 workers with a high TWA-FA con-
centration [2.14 (1.38–4.14) ppm] was compared with 12 
controls [0.026 (0.015–0.026) ppm]. In the CFU-GM cells, 
monosomy for chromosome 7 increased from about 5 % 
in the controls to about 10 % in the FA-exposed, and tri-
somy for chromosome 8 increased from about 4 % to about 
12 %, respectively. As all participants had cultivation to 
CFU-GM cells, this allowed investigation of aneuploidy 
and structural chromosome aberrations in an expanded sub-
set of 29 workers and 23 controls with a TWA-FA concen-
tration of 1.38 (0.78, 2.61) ppm and 0.026 (0.015, 0.026) 
ppm, respectively. Monosomy was significantly increased 
for 16 of 24 chromosomes with the highest significance for 
chromosomes 1, 5, 7, 4 and 19, shown in decreasing order 
of significance. Trisomy was significantly increased for 6 
of 24 chromosomes, which were chromosomes 5, 19, 21, 
1, 20 and 16. Tetrasomy was significantly increased for 
10 of 24 chromosomes, with the highest significance for 
chromosomes 4, 15, 17, 14 and 3. Structural chromosome 
aberration was only detected for chromosome 5 (Lan et al. 
2015). It is noted that the two studies are subsets from the 
same cross-sectional study with high FA exposures. It is a 
reasonable assumption that the peak exposures may have 
been much higher. Further, it is unlikely that FA reaches the 
internal organs, including the bone marrow and the bone 
marrow progenitor cells. Also, the studies are not consist-
ent with in vitro effects of FA as reviewed below.
Blood from healthy young non-smoking volunteers were 
used to derive CFU-GM cells, which were investigated for 
monosomy and trisomy from chromosomes 5, 7 and 8. The 
frequency of aneuploidy metaphases was similar and low 
for the three chromosomes and not increased by exposure 
to 10–50 µM FA during the cultivation. In contrast, vincris-
tine (an aneugen) increased monosomies for all three chro-
mosomes, but caused no clear increase in trisomy (Kueh-
ner et al. 2012). This was further supported by an in vitro 
study in FA-exposed TK6 cells, where gene expression was 
analysed using a whole-genome microarray. This showed 
that the gene expression profile in FA-exposed cells was 
closer to the two clastogens, methyl methanesulfonate and 
ethyl methanesulfonate, than to the two aneugens, colcemid 
and vincristine (Kuehner et al. 2013). Additionally, human 
peripheral blood mononuclear cells were cultivated to 
derive erythropoietic progenitor cells, which were exposed 
to 0 (control group), 50 or 100 µM FA in vitro. The FA 
exposure did not significantly increase monosomy or tri-
somy for chromosome 7 and 8, respectively, even though 
a high number of cells (~7000) were investigated. Never-
theless, combining monosomies for chromosomes 7 and 8 
increased the frequency from 1.45 % in the control group 
to 1.93 % (statistically significant) in the 50 µM group, 
but the frequency was decreased to 1.24 % in the 100 µM 
group. Combining trisomies for chromosomes 7 and 8 
resulted in a frequency of 0.03 %, 0.13 % (statistically sig-
nificant) and 0.09 % (not significant), respectively (Ji et al. 
2014). It is noted that the frequencies of aneuploidies were 
much lower than in the Zhang et al. (2010) and Lan et al. 
(2015) studies.
Overall, several recent studies confirm a genotoxic effect 
of FA in blood lymphocytes; the genotoxic effects indicate 
risk of developing malignant diseases (e.g. Norppa et al. 
2006; Kirsch-Volders et al. 2014). However, with regard 
to assessing risk, previously conducted studies are still the 
most informative for setting an IAQG for FA. Thus, in a 
controlled chamber study with volunteers exposed to FA 
for 4 h per day for 5 days, where the FA concentrations 
ranged from 0.3 to 0.7 ppm with peaks up to 0.8 ppm, no 
relevant genotoxic effect was found in blood lymphocytes 
(Zeller et al. 2011). In contrast to the results from human 
studies, rats exposed for 6 h per day, 5 days per week for 
4 weeks at FA concentrations up to 15 ppm showed no gen-
otoxic effects in peripheral blood cells in the Comet, MN 
and SCE tests (Speit et al. 2009). Overall, an IAQG has to 
be below 1 ppm for both mean and peak FA exposures as 
previously suggested (Nielsen and Wolkoff 2010; Nielsen 
et al. 2013). Genotoxic effects can be used as a proxy for 
the risk of malignant diseases, but because comprehensive 
long-term epidemiological and animal studies are available 
with the ultimate endpoints, these studies together with the 
toxicokinetic studies should constitute the appropriate and 
final basis for evaluation of the WHO guideline value on 
cancer risk assessment.
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Genetic polymorphisms and genotoxicity in human 
blood cells
The study by Pontel et al. (2015) identified potential path-
ways in which polymorphisms in humans may give rise 
to especially sensitive individuals that must be considered 
in the guideline setting. ADH5 (also termed ALD3) is the 
key FA-metabolizing enzyme (Staab et al. 2008). Expres-
sion of mRNA of ADH5 in peripheral leucocytes was not 
affected by FA exposures in a controlled chamber study 
with 4 h of FA exposure per day for 5 days with FA con-
centrations between 0.3 and 0.7 ppm and with peaks up to 
0.8 ppm (Zeller et al. 2011). However, 38 single nucleo-
tide polymorphisms (SNPs) were described that are nearly 
all rare (<1 %) alleles, in agreement with two of the poly-
morphisms (rs11568816, investigated in 150 subjects, and 
17028487, investigated in 70 subjects) that showed no vari-
ant allele. As regards the third polymorphism (rs13832), 
41 % of alleles were heterozygous (G/T) and 59 % were 
homozygous (44 % T/T and 15 % GG). These polymor-
phisms had no influence on the expression of blood cell 
mRNA of ADH5, and FA exposure of cultivated blood 
cells showed no difference in DPX levels (Just et al. 2011). 
In a recent study, pathology laboratory employees with a 
mean peak FA exposure of 1.14 ppm and with a maximum 
of 2.91 ppm were investigated for genotoxic effects of FA 
in the cytokinesis-block micronucleus assay. Two ADH5 
polymorphisms (Val309Ile and Asp353Glu) did not show 
biologically relevant effects on FA-induced genotoxicity 
(Ladeira et al. 2013).
Numerous studies have shown that polymorphisms 
involved in DNA repair and metabolism influence genetic 
damage in human peripheral blood lymphocytes (e.g. 
Dhillon et al. 2011). Costa et al. (2015) investigated poly-
morphisms of three genes, XRCC1, PARP1 and MUTYG, 
which participate in the BER pathway (Dhillon et al. 
2011), and XRCC3, which participates in the HR path-
way (de Oliveira et al. 2014); mean exposures were up to 
1.39 ppm and peak exposures up to 3.2 ppm. The inves-
tigated endpoints included CAs, aneuploidies, aberrant 
cells, multi-aberrant cells and percentage of DNA in the 
comet tail. The XRCC1 allele rs1799782 (Arg194Trp) 
was associated with more DNA in the tail (damage) in 
the heterozygous (Arg/Trp) than in the homozygous 
(Arg/Arg) wild type; none of the other endpoints showed 
an association with this allele. The authors mention that 
the effect was only observed in the heterozygous group 
and the group contained a small number of FA-exposed 
individuals. The PART1 allele rs1136410 had lower 
occurrence (protective effect) of multi-aberrant cells in 
the heterozygous ((Val/Ala) type than in the homozy-
gous (Val/Val) wild type. None of the other investigated 
alleles (XRCC1 rs25487, MUTYH rs3219489 and XRCC3 
rs861539) showed any significant association with the 
FA-induced effects in the investigated endpoints. It is 
noted that a high number of statistical tests were con-
ducted and that this may have caused mass significance. 
In previous studies, the XRCC3 allele with the same pol-
ymorphisms was investigated in the cytokinesis-block 
micronucleus assay with MN, nucleoplasmic bridges and 
nuclear buds (NBUD) as the endpoints (Ladeira et al. 
2013), where the Thr241Met had a higher frequency of 
NBUD formation. It is noted that no increase was seen in 
the two other endpoints or in any of the endpoints stud-
ied in the recent investigation by Costa et al. (2015). In 
a study by Costa et al. (2008), polymorphisms in ERCC1 
allele rs3212986, ERCC4 rs180067, ERCC5 rs17655 and 
ERCC5 rs2227869 were investigated, which are all genes 
involved in the NER pathway (Dhillon et al. 2011); mean 
exposures were up to 1.58 ppm, and peak exposures up to 
4.43 ppm. The investigated endpoints were MM, SCE and 
the comet tail length. The authors did not find any effect 
in these endpoints.
Several phase I and phase II metabolizing enzymes have 
also been investigated for effects of polymorphisms on FA-
induced genotoxicity. Cytochromes P450 (CYPs) are phase 
I mono-oxygenase enzymes, where CYP2E1 is involved in 
metabolism of many carcinogenic and non-carcinogenic 
compounds (Trafalis et al. 2010). The genotoxicity of FA 
was investigated in blood lymphocytes of FA-exposed sub-
jects with a CYP2E1 polymorphism (rs6413432) with the 
wild type carrying the T/T allele versus the combined T/A 
plus A/A allele group. CAs were not affected by the alleles, 
whereas the T/A plus A/A allele group had a lower amount 
of DNA in the comet tails; the authors suggested that this 
represented a protective effect (Costa et al. 2015).
Glutathione S-transferases (GSTs) are phase II enzymes 
that catalyse conjugations of glutathione to electrophilic 
centres of reactive compounds. Polymorphisms of the 
GSTM1, GSTT1 and GSTP1 genes have been associated 
with lymphohaematopoietic malignancies or predisposition 
to these (Dahabreh et al. 2010; Bin and Luo 2013; He et al. 
2014). Comparing FA-induced genotoxicity in the GSTM1 
null versus in the GSTM1 non-null and in the GSTT1 null 
versus in the GSTT1 non-null polymorphisms, respec-
tively, showed no consistent difference between the respec-
tive null and non-null genotypes (Costa et al. 2008; Jiang 
et al. 2010; Santovito et al. 2011; Zeller et al. 2012; Costa 
et al. 2015). Furthermore, FA-associated genotoxicity was 
investigated in the GSTP1 gene, where the isoleucine (Ile) 
amino acid at position 105 in the wild type (Ile/Ile) was 
substituted with valine (Val) with the heterozygous (Ile/
Val) genotype and the mutant (Val/Val) genotype. Whereas 
FA-associated CAs were lower in the combined Ile/Val plus 
Val/Val group than in the Ile/Ile group (Costa et al. 2015), 
no effect was observed in the comet assay (Jiang et al. 
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2010; Costa et al. 2015), and MN was marginally (~26 %) 
increased (Jiang et al. 2010).
In conclusion, no major influence of polymorphisms has 
been identified that constitutes an important risk factor with 
regard to the genotoxic effects of FA exposure.
Oxidative stress‑associated genotoxicity in animal 
studies
Reactive oxygen species (ROS) may be caused by air pol-
lutants (Azad et al. 2008), for example as a consequence 
of exposure to inhaled particles and their associated com-
pounds (Møller et al. 2014). Reactive oxygen species 
(ROS), such as superoxide anion, hydrogen peroxide, 
hydroxyl radical and hydrochlorous acid, and reactive 
nitrogen species (RNS), such as nitric oxide and peroxyni-
trite, are highly reactive towards lipids, proteins and DNA 
(Azad et al. 2008; Filomeni et al. 2015) that may cause cel-
lular adaptation by up-regulation of antioxidant and repair 
mechanisms or cell death and cancer (Azad et al. 2008; 
Filomeni et al. 2015).
In vitro exposure of the lung A549 epithelial cell line 
to FA caused DPX formation, malondialdehyde formation 
and up-regulation of DNA transcription factors (NF-ĸB and 
AP-1). Moreover, it also caused a decrease in superoxide 
dismutase and glutathione peroxidase, which were attenu-
ated by antioxidants such as curcumin (Zhang et al. 2013a) 
and selenium (Shi et al. 2014), indicating that genotoxic-
ity and ROS formation can play a direct role in FA-induced 
cellular toxicity. Recent studies in mice and rats of the 
association between FA exposures and DNA damage and 
ROS effects are evaluated below.
Acute 2–24 h of exposure at 0 (control) and 0.1 ppm 
FA were studied in ICR mice. The marker, 8-hydroxy-
2′-deoxyguanosine, of ROS-induced DNA damage was 
unchanged in urine, plasma, lungs, liver and brain in the 
FA-exposed animals. NO production was measured after 
conversion to the stable NO3
− ion. Plasma NO3
− levels 
were only increased after 24 h of exposure. The lung NO3
− 
level was unaffected by the exposures. In contrast, the liver 
and brain NO3
− levels decreased after ≥2 h of exposure, 
and the urinary NO3
− levels decreased after ≥8 h of expo-
sure. Plasma interleukin-6 (IL-6) was unaffected by the 
exposures, and no tissue damage was observed. However, 
exposure at 3 ppm for 24 h increased superoxide dismutase 
in urine and plasma, but not in the liver (Matsuoka et al. 
2010). It is noted that the low FA concentration did not 
show consistent adverse effects, including oxidative stress.
A recent comprehensive study in BALB/c mice evalu-
ated DPX formation, decrease in glutathione (GSH), 
increase in ROS, and increase in malondialdehyde (MDA) 
formation in bone marrow, peripheral blood mononuclear 
cells (PBMC), lungs, liver, spleen and testes. Mice were 
exposed to 0 (control), 0.5, 1 and 3 mg/m3 FA 8 h/day for 
7 consecutive days. The liver was the most sensitive organ 
for DPX formation, decrease in GSH and increase in ROS 
(LOAEC: 0.5 mg/m3). The NOAEC for DPX formation in 
the bone marrow, spleen and testes was 0.5 mg/m3. Least 
sensitive was the PBMC and the lungs, where no increase 
in DPX was observed at 3 mg/m3. The lung was highly 
sensitive to a decrease in GSH with a LOAEC of 0.5 mg/
m3. The bone marrow, PBMC and spleen had an interme-
diate sensitivity (NOAEC: 0.5 mg/m3). The NOAEC for 
the testes effect was higher (1 mg/m3). No ROS formation 
occurred at 0.5 mg/m3 (NOAEC) in the bone marrow, the 
lungs, spleen and testes. PBMC was less sensitive with a 
NOAEL at 1 mg/m3. For MDA formation, the NOAEC was 
0.5 mg/m3 for the bone marrow, lungs, liver, spleen and tes-
tes effect, whereas the NOAEC for the PBMC was 3 mg/
m3. To further substantiate the effect of oxidative stress, 
two groups of mice were exposed to 3 mg/m3 FA, where 
one group was given an additional oral dose of 100 mg/kg 
GSH after each FA exposure. In the GSH-treated group, 
bone marrow, PBMC, lungs, liver, spleen and testes had 
higher GSH levels than in the GSH-untreated group. Fur-
thermore, ROS and MDA formation was lower than in the 
untreated group. The GSH group had lower DPX forma-
tion, except in the lungs, where the level was similar in the 
GSH-treated and untreated group. It is mentioned that mice 
reduce their respiratory minute volume, which may induce 
oxidative stress (Ye et al. 2013). It is noted that the liver 
was the most sensitive organ (LOAEC: 0.5 mg/m3) and the 
NOAEC was higher (0.5 mg/m3) for bone marrow effects.
The finding that FA exposures can cause DPX forma-
tion at distant sites was supported by two previous stud-
ies of Kunming mice that were exposed continuously for 
72 h at the above-mentioned concentrations. DPX forma-
tion was increased significantly in the bone marrow (Cheng 
et al. 2010) and the kidney and testes (Peng et al. 2006) at 
0.5 mg/m3 (LOAEC), whereas the NOAEC for DPX for-
mation in the liver was 0.5 mg/m3 (Peng et al. 2006).
In another recent study, male BALB/c mice were 
exposed to 0 (control), 0.5 and 3 mg/m3 FA, 8 h/day, 
5 days/week for 2 weeks (Zhang et al. 2013b). At the end 
of the study, the red blood cell counts were decreased con-
centration dependently (17 and 27 %, respectively) as were 
the white blood cell count (43 and 52 %, respectively). 
The decrease in lymphocytes was similar (~40 %) in the 
exposed groups. The increase in platelets was 109 and 
67 %, respectively. No change was observed in neutrophilic 
granulocytes and intermediate cells. Bone marrow histol-
ogy qualitatively suggested that the number of megakaryo-
cytes (producing thrombocytes) increased with increasing 
FA concentrations. At 3 mg/m3, myofibrosis was observed. 
Bone marrow ROS increased concentration dependently, 
and the increased ROS was observed already at 0.5 mg/
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m3. At 3 mg/m3, a significant decrease was observed in 
bone marrow GSH and glutathione S-transferase theta 1 
(GSTT1), whereas a significant increase was observed in 
cytochrome P450 1A1 (CYP 1A1), NF-ĸB, TNF-α, IL-1β 
and caspase-3 activity. It is noted that the LOAEC was 
0.5 mg/m3 with haematological changes, increased bone 
marrow megacaryocytes and increased ROS formation.
ICR mice were exposed at 0 (controls), 20, 40 and 
80 mg/m3 (0, 16, 33 and 65 ppm, respectively) for 2 h 
per day for 15 days. White blood cell and platelet counts 
were decreased at ≥40 mg/m3, whereas the red blood cell 
count was unaffected at 80 mg/m3. In the bone marrow, 
the most sensitive endpoints were a decrease in superoxide 
dismutase and an increase in MDA (both oxidative stress 
markers), which were significant at 20 mg/m3 (LOAEC). 
At ≥40 mg/m3, the bone marrow content of Bax and 
cytochrome c (both pro-apoptotic) increased, whereas the 
Bcl-2 protein (anti-apoptotic) decreased. In the bone mar-
row at 80 mg/m3, a decrease occurred in nucleated cells, in 
mitochondrial membrane potential and in colony formation 
at in vitro cultivation. Also at 80 mg/m3, there was arrest 
in the S phase of the cell cycle (Yu et al. 2014). It is noted 
that the FA concentrations are at extremes. They are high 
compared with the mucosal detoxification mechanisms, 
and an extreme decrease [>60 %, calculated from Nielsen 
et al. (1999)] in respiratory ventilation is predicted. This 
study required high FA concentrations (≥40 mg/m3) for 
change of the blood constituents, which is different from 
the above-mentioned studies.
Rats were exposed 8 h per day, 5 days per week for 4 or 
13 weeks at 10 and 20 ppm FA, respectively. In the heart, 
the superoxide dismutase activity increased significantly 
in all exposed groups. The catalase activity decreased sig-
nificantly in the 4-week groups, but the decrease was not 
significant in the 13-week groups. The heart lipid peroxida-
tion (thiobarbituric acid reactive) products increased non-
significantly in the FA groups. The heart NO levels were 
not affected by the FA exposures (Güleç et al. 2006). This 
study applied very high FA concentrations and, at most, 
it showed a marginal and non-significant increase in ROS 
formation.
Wistar rats were exposed to 0 (control), 0.5, 1 and 3 mg/
m3 FA continuously for 72 h. In the bone marrow, DPX 
was decreased by 14 % at 0.5 mg/m3, unaltered at 1 mg/m3 
and significantly increased by 26 % at 3 mg/m3 when com-
pared with the control group. In the comet assay, the per-
centage of DNA in the tail increased significantly to 250 % 
at 0.5 mg/m3 and to 455 % at 1 mg/m3, but no change 
occurred in the 3 mg/m3 group. The tail moments showed 
a similar pattern (Wang et al. 2009). The slight increase in 
the DPX formation in the 3 mg/m3 might support a slight 
oxidative stress response associated with a decrease in res-
piratory ventilation, although rats are less prone to decrease 
ventilation compared with mice (Nielsen et al. 2013). As 
FA causes DPX formation, DNA migration in the comet 
assay is expected to decrease and not to increase (Speit 
et al. 2009). It is noted that the bell-shaped response in 
the comet assay is unexplained, as it is not related to an 
increased oxidative stress or to a potential systemic absorp-
tion of FA as no effect was observed at 3 mg/m3. It is coun-
ter-intuitive that the bell-shaped relationships are relevant 
proxies for carcinogenic effects, as these effects increase 
monotonously with exposure concentrations in animal and 
human studies as discussed below.
In a previous study, rats were exposed 6 h per day, 5 days 
per week for 4 weeks at FA concentrations up to 15 ppm 
and showed no genotoxic effects in peripheral blood cells 
in the Comet, MN and SCE tests (Speit et al. 2009).
For risk assessment, it is noted that the observed effects 
occurred after short-term exposures and effects show high 
variability within mice studies as well as between mice and 
rat studies. The Ye et al. (2013) study observed no increase 
of DXP formation in PBMC at 3 mg/m3. This indicates that 
FA neither reaches the blood compartment in mice nor can 
be distributed to the internal organs, in agreement with the 
isotope-labelled FA studies in rats and monkeys (Lai et al. 
2016). Overall, this strongly suggests that the DPX forma-
tion and the oxidative stress in distant organs are secondary 
effects of portal-of-entry effects.
Sensory-irritation-induced effects are candidates for 
a FA-induced portal-of-entry effect. Thus, BALB/c mice 
experienced a decrease in their respiratory ventilation due 
to sensory irritation in the upper airways at ≥0.3 ppm 
(0.37 mg/m3). The examples below indicate that hypoxia 
may cause profound physiological changes; in humans, 
hypoxia is known inter alia from obstructive sleep apnoea. 
Chronic intermittent hypoxia may cause cardiovascular 
deterioration in animals and humans that may be due to oxi-
dative stress, systemic inflammation, sympathetic activa-
tion, decrease of bone marrow-derived endothelial progeni-
tor cell mobilization, which decreases repair of endothelial 
injuries, systemic and pulmonary arterial hypertension, and 
heart failure (Dumitrascu et al. 2013; Wang et al. 2013b; 
Yin et al. 2012, 2014). In the lungs, hypoxia can induce 
oxidative stress and inflammation that can cause bronchial 
vasoconstriction, pulmonary oedema, vascular remodel-
ling and pulmonary hypertension (Araneda and Tuesta 
2012). In addition, oxidative stress in the lungs may induce 
autophagy, which is a catabolic process that regulates turn-
over of proteins and eliminates damaged organelles and 
protein aggregates (Malaviya et al. 2014). Furthermore, 
hypoxia may cause epigenetic effects due to dysregulation 
of histone methylation (Chervona and Costa 2012).
Estimated from Nielsen et al. (1999), BALB/c mice 
decrease their respiratory ventilation between 4 and 15 % 
at 0.4 ppm (0.5 mg/m3), suggesting that hypoxia-induced 
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oxidative stress may be a potential secondary effect, also 
noted by Ye et al. (2013). This agrees with the higher FA 
concentration needed for DPX formation in rats (Wang 
et al. 2009). The concentration that depresses the respira-
tory rate by 50 % (RD50) in mice is about 4–8 ppm (Chang 
et al. 1981; Nielsen et al. 1999), but about 30 ppm in rats 
(Chang et al. 1981); the corresponding decrease in res-
piratory ventilation was 47 and 45 %, respectively (Chang 
et al. 1981). The difference in the FA effect on the respira-
tory ventilation has toxicological significance. For exam-
ple, the nasal tissue in mice received half the dose per unit 
area and time at 15 ppm compared with the dose in rats, 
which explains the lower frequency of nasal cancer in mice 
(Barrow et al. 1983). For that reason, a systemic effect of a 
potentially absorbed dose should also be lower in mice than 
in rats. However, the opposite is the case with regard to 
DPX formation in the bone marrow; here DPX formation 
is associated with the decrease in ventilation. Moreover, 
in the bone marrow, hypoxia and ROS formation play an 
important role in regulation of the hematopoietic stem cells, 
where oxygen sensors (hypoxia-inducible factors) regulate 
numerous genes controlling cell proliferation and survival, 
angiogenesis, metabolism and haematopoiesis (Zhang 
and Sadek 2014; Morikawa and Takubo 2016). Although 
sensory-irritation-induced decrease in respiratory rate and 
ventilation in rodents is one of the most commonly used 
endpoints for the study of irritation of chemicals, numer-
ous other less well-investigated reflex-induced reactions are 
also caused by sensory irritation. These reactions include 
decreased heart rate, increased peripheral vasoconstric-
tion, increase in systolic blood pressure, decreased renal 
blood flow and clearance, and decreased coronary blood 
flow (Alarie 1973). Additionally, FA induces other sen-
sory-irritation effects such as decrease in body temperature 
and decrease in total metabolism, indicated by a decrease 
in CO2 production. These effects were more prominent in 
mice than in rats (Jaeger and Gearhart 1982). On the whole, 
the observed FA effects are in a concentration range where 
sensory irritation is present and where one or more of the 
secondary sensory-irritation effects may play a role in the 
observed systemic effects; low oxygen supply may cause 
oxidative stress in humans (Askew 2002), but this may be 
less important in rats (Nagatomo et al. 2012), suggesting 
that species differences may exist.
Risk assessment should be based on relevant long-term 
studies in mice and rats and not on short-term studies in 
these species. The 2-year study of FA exposure in mice and 
rats found only nasal cancer at levels up to 14 ppm (17 mg/
m3) FA where all organ systems were investigated (Kerns 
et al. 1983). Thus, speculations about the consequences of 
the internal organ effects in the short-term studies cannot 
overrule the findings in the long-term studies. The WHO 
(2010) guideline prevents sensory irritation; this threshold 
is considered precautionary and is not contradicted by the 
short-term studies discussed above.
Transcriptional regulation by microRNAs
MicroRNAs (miRNAs, miRs) are single-stranded oligonu-
cleotides non-coding RNA sequences of about 22 nucleo-
tides. miRNAs are important regulators of gene expression 
at the posttranscriptional level. This may result in transcrip-
tional repression, mRNA degradation or up-regulation of 
gene expression (Vrijens et al. 2015).
Epigenetic changes were studied based on expression 
profiles of 534 miRNAS in the nasal tissue of nonhuman 
primates. Thus, cynomolgus macaques were exposed to 
0 (controls), 2 and 6 ppm FA for 6 h/day for 2 consecu-
tive days. At 2 ppm, three miRNAs (miR-142-3p, miR-145 
and miR-203) were significantly decreased. A decrease in 
miR-142-3p may be related to the expression of genes that 
increase cell proliferation. At 6 ppm, FA disrupted expres-
sion levels of 13 miRNAs, indicating an exposure-depend-
ent effect. The miR-125b was the highest up-regulated 
miRNA, and thus it was associated with a decrease in apop-
tosis-related gene expression. The most decreased miRNAs 
at 6 ppm FA were miR-145 and miR-142-3p (Rager et al. 
2013).
miRNA and mRNA expression profiles were also stud-
ied in the nasal respiratory epithelium, in white blood 
cells (WBC), and bone marrow cells in FA-exposed rats. 
Exposures were with labelled FA (13CD2O) at 0 (control) 
or 2 ppm FA for 7, 28 or 28 days followed by a 7-day 
recovery period. Exposure lasted 6 h per day. Two ppm 
was selected as this concentration altered gene expression, 
caused DNA adduct formation, but only caused minimal 
inflammatory cell infiltration in the nose. Alteration of 
expression of 84, 59 and 0 miRNAs was observed among 
695 miRNAs in the nasal tissue in the three FA-exposed 
groups. In the WBC, the altered miRNA expression was 
31, 8 and 3, respectively. The miRNA expression was not 
altered in the bone marrow. The miRNA expression pro-
file showed a strong time-dependent and tissue-specific 
profile. The expression of miRNAs in the nose was asso-
ciated with down-regulation of tumour-suppressor activity. 
It was predicted that miRNA regulated up to 35 % of FA-
induced transcriptional responses. The miRNA expression 
changes did not persist in the nose after 7 days of recov-
ery. Expression of mRNA levels of 27,342 genes was also 
studied in the nose and WBC. FA exposure caused differ-
ential expression of 830 and 42 genes in the nose in the 
7-day and 28-day groups, respectively. In the 7-day group, 
25 % of the FA-responsive transcripts represent olfac-
tory receptors. In WBC, altered gene expression was seen 
in 96 in the 7-day group and in 130 in the 28-day group. 
Both in the nose and the WBC, gene expression was time 
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dependent. Of the FA-responsive transcripts in the nose, 
only 2 % were also responsive to FA exposure in the WBC 
with 1 % in the same direction of altered expression. Path-
way analyses of miRNAs and mRNA profiles revealed a 
total of 45 pathways associated with FA-induced tran-
scriptomic changes where enrichment of immune system/
inflammation signalling was observed both in the nose 
and in the WBC. From the sensitive biomarker FA-dG, 
external FA-dG adducts were detected in the nasal DNA, 
but no external generated FA-dG adducts were found in 
the WBC DNA, indicating that external FA did not reach 
the WBC. This led the authors to hypothesize that FA-
induced inflammatory signals originating in the nose drive 
the effects observed in WBC (Rager et al. 2014). Overall, 
this study supports that the FA-induced effect on the WBC 
may be a secondary effect from the upper airways as no 
FA is absorbed beyond the portal-of-entry mucosa.
In three groups, mixtures of FA, benzene, toluene 
and xylene, were investigated in mice exposed 2 h/day, 
5 days/week for 2 weeks and compared with an unex-
posed control group. Group 1: 3 + 3.3 + 6 + 6 mg/m3, 
respectively; Group 2: 5 + 5.5 + 10 + 10 mg/m3, respec-
tively; and Group 3: 10 + 11 + 20 + 20 mg/m3, respec-
tively. The bronchoalveolar lavage fluid content of IL-8 
increased significantly in the exposed groups with a similar 
increase (~25 %). In Group 1, lung tissue GSH decreased 
non-significantly (15 %), whereas a significant increase 
was observed in the total nitric oxide synthase (25 %) and 
in the inducible nitric oxide synthase (66 %). In group 
2, the values were 29, 72 and 78 %, respectively, and in 
Group 3, values were 29, 62 and 36 %, respectively. In 
the lungs in Group 1, 662 miRNAs were down-regulated 
and 96 were up-regulated, in Group 2, 592 were down-
regulated and 68 up-regulated, and in Group 3, 11 were 
down-regulated and 18 up-regulated. In Group 1, the most 
significantly up-regulated miRNAs were miR-1187, miR-
125a-3p, miR-466c-5p, miR-5105 and miR-3472, whereas 
the most significantly down-regulated was miR-125b-5p. 
These miRNAs were biologically linked to cell death, cell 
adhesion and metal ion transport (Wang et al. 2014). It is 
noted that the FA concentrations in themselves decrease 
the respiratory ventilation substantially, which may cause 
hypoxia. The exposure-dependent effects were limited or 
absent; the miRNAs were changed minimally at the highest 
exposure concentration. Additionally, FA is not expected to 
reach the lungs if inhaled as a gas. Also, it is not possible to 
deduce effects of gaseous FA due to mixed exposure.
The WHO (2010) IAQG is for gaseous FA exposure 
with the NOAEL (1.25 mg/m3) for nasal epithelial inflam-
mation in rats is used as a critical effect in the setting of 
the guideline. Thus, there is no contradiction between the 
guideline value and the new studies, which have been con-
ducted at concentrations in the effect-range.
Carcinogenicity
Previous evaluations
The histopathological NOAEL was 1 ppm for damage 
of the nasal epithelium in rats and monkeys, repeatedly 
exposed from 6 to 22 h per day (c.f. Nielsen and Wolkoff 
2010). This suggested that the FA concentration may be 
more important for cytotoxicity and cell proliferation than 
the total FA dose. FA caused nasal squamous cell carci-
noma (SCC) that is the critical cancer type in rats. Fischer 
344 and Sprague–Dawley rats were more sensitive in devel-
oping SCC than Wistar rats, mice and hamsters. Results 
from four long-term studies with the sensitive rat strains 
are combined in Table 2, showing an apparent NOAEC 
for SCC at 2 ppm (WHO 2010; Nielsen and Wolkoff 
2010; Nielsen et al. 2013). In rats, epithelial cell damage-
induced cell proliferation was shown experimentally to 
be a key mechanism for development of SCC; in Wistar 
rats, no SCC could be induced at ≤1 ppm FA, even with 
induced cell proliferation (Woutersen et al. 1989). The two 
NOAECs were used in the WHO (2010) risk characteriza-
tion. In addition to SCC in the rat nose, FA exposure also 
induced a lower number of (benign) polypoid adenomas at 
≥2 ppm FA (RAC 2012). These tumours were not consid-
ered in the WHO (2010) evaluation. This is supported by a 
recent evaluation that concluded that this type of lesion is 
unlikely to be a pre-stage to the (malignant) SCC (Gelbke 
et al. 2014).
In rats and mice, long-term inhalation of FA has not 
shown convincing development of lymphohaematopoietic 
malignancies (WHO 2010; Nielsen and Wolkoff 2010; 
Golden 2011; Rhomberg et al. 2011; RAC 2012). Never-
theless, if such an effect was masked by a high mortality in 
rats (IARC 2012) and mice (WHO 2010; IARC 2012) due 
Table 2  Nasal epithelial squamous cell carcinomas (SCC) in com-
bined groups of male and female rats from four long-term inhalation 
studiesa with formaldehyde (FA) exposures
a Kerns et al. (1983), Sellakumar et al. (1985), Monticello et al. 
(1996) and Kamata et al. (1997). For review of details, see Nielsen 
and Wolkoff (2010) and Nielsen et al. (2013)




2 0/364 (0) (apparent NOAEC)
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to development of nasal SCC at high exposure levels, the 
incidence of lymphohaematopoietic malignancies would be 
much lower than that of SCC in rats, why SCC was consid-
ered the more sensitive endpoint (WHO 2010).
Meta-analyses were used to identify associations 
between FA exposures and cancer (WHO 2010; Nielsen 
and Wolkoff 2010). Except for one meta-analysis, which 
has been repeated and updated (Schwilk et al. 2010), none 
of the other meta-analyses showed any clear association 
between the different types of cancer and FA exposure. 
The meta-analysis by Schwilk et al. (2010) used 13 cohort 
studies and one nested case control study. The relative 
risk (RR) was selected from the highest exposure group in 
each study; the intention was to evaluate potential effects 
of high FA exposures. Furthermore, when RRs from dif-
ferent exposure metrics were given, the value was selected 
in the order: peak exposure, average intensity, cumulative 
exposure, exposure duration, and earlier date of hire. The 
meta RR (95 % CI) was 1.5 (1.1–2.1) for leukaemia, 2.5 
(1.4–4.3) for myeloid leukaemia, and 0.95 (0.6–1.5) for 
lymphatic leukaemia. Combining all exposed individuals 
into one group, the mRR was 1.07 (0.86–1.32). This sug-
gested that high exposures may cause leukaemia, especially 
myeloid leukaemia. However, the analysis has been criti-
cized for methodological shortcomings such as not using 
all available information and choosing highest exposure 
cut points that vary across the combined studies, which 
may cause heterogeneity; the homogeneity tests used in the 
study are considered insensitive. Predictive intervals are 
recommended instead of confidence intervals, and the find-
ings of elevated leukaemia and myeloid leukaemia risks 
are far from significant if using these techniques in the data 
analyses (Morfeld 2013).
Recently, two comprehensive reviews of epidemiologi-
cal studies on lymphohaematopoietic malignancies were 
published. Thus, eight case–control and 24 cohort studies 
were evaluated by Rhomberg et al. (2011), and 17 case–
control and 22 cohort studies were reviewed by Checkoway 
et al. (2012). None of these reviews found any consistent or 
strong evidence that FA was causally related to any of the 
lymphohaematopoietic malignancies, including myeloid 
leukaemia.
Recent evaluations by national or international panels
A recent joint EU evaluation of cancer hazards was per-
formed by RAC (2012). After long-term inhalation in rats 
and mice, nasal SCC and benign tumours (papillomas and 
adenomas) were the key effects. Moreover, RAC evalu-
ated a series of epidemiological studies, including their 
strengths and weaknesses, and found the key effect of 
exposure to be nasopharyngeal cancer (NPC). Based on 
the overall consistency within and between species, and 
biological plausibility (comprising all genotoxic effects 
of FA), RAC concluded that there is “limited evidence of 
carcinogeneity in humans (Car. 1B)”; the human evidence 
was from nasopharyngeal cancer. With regard to inhalation, 
RAC did not find evidence of tumours outside the respira-
tory tract.
A different conclusion was reached by NRC (2014), 
which found that there was clear and convincing epidemio-
logical evidence (Sufficient evidence) of a causal relation-
ship between FA exposure and occurrence of nasopharyn-
geal and sinonasal cancer, and myeloid leukaemia; the 
carcinogenic effect at any additional sites does not meet the 
requirement of limited evidence. Sufficient evidence was 
accepted if at least two strong or moderately strong stud-
ies with different study design and populations showed an 
association between FA exposure and a specific cancer type 
and for which chance, bias and confounding could reason-
ably be ruled out. An epidemiological study was considered 
strong if it comprised a large population with long dura-
tion of exposure and sufficient follow-up for latency, had 
an appreciable FA gradient, and the FA exposure was well 
characterized. Accept of a systemic carcinogenic effect 
does not require that the mechanism is known or FA is 
systemically available. Also, the negative findings did not 
necessarily negate positive findings. It is mentioned that the 
evaluation is hazard based and not a risk assessment. It is 
noted that limitations of the key studies were not addressed, 
although they have been discussed intensively in the scien-
tific literature. The different conclusions between the two 
evaluations are due to differences in evaluation criteria. 
All the recent studies that were considered to be strong by 
NRC (Beane Freeman et al. 2009, 2013; Hauptmann et al. 
2009; Meyers et al. 2013) are considered below.
Identification of studies with quantitative exposure 
response relationships
Quantitative FA exposures and associations with different 
types of cancer are available from three major and recently 
updated occupational cohorts: the National Cancer Insti-
tute (NCI) cohort (Beane Freeman et al. 2009, 2013), the 
British (UK) factory cohort with exposures to FA (Cog-
gon et al. 2014), and the US NIOSH Garment Industry 
cohort (Meyers et al. 2013). Moreover, data were also 
available from a case–control study of cancer among US 
embalmers (Hauptmann et al. 2009). The NCI and the UK 
cohorts are considered to have the best exposure assess-
ments (Checkoway et al. 2012) and thus to be the key stud-
ies for establishing exposure–response relationships. The 
NIOSH cohort had limitations in the exposure assessment 
(Checkoway et al. 2012), but due to the size of the cohort, 
it is considered valuable for hazard identification (Table 3). 
The US embalmer study reported an increase in myeloid 
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Table 3  Cancer risks from formaldehyde exposures in three recently updated occupational cohorts
The US National Cancer Institute (NCI) cohort comprised 25,619 workers employed in 10 U.S. formaldehyde producing or using facilities. 
Workers were employed prior to January 1 1966 and were followed up through 31 December 2004 (Beane Freeman et al. 2009; Beane Freeman 
et al. 2013; number of death was 13,951 [11,346 among exposed and 2605 among unexposed (Beane Freeman et al. 2013)]. Exposures were 
from Beane Freeman et al. (2009). A British (UK) cohort from six British factories, comprising 14,008 men followed up from 1941 through 
December 2012; number of death were 7378 (Coggon et al. 2014). The US National Institute for Occupational Safety and Health had established 
a cohort with 11,034 employees in three garment facilities (US garment worker cohort); number of death was 3915. The study was updated 
through 31 December 2008 (Meyers et al. 2013)
a Standardized mortality ratio (SMR) was obtained by comparison with the national death rates. The number of observed death due to the type 
cancer among exposed workers is indicated by “O” and the expected number of cases by “E” where relevant for calculation of SMR. When a 
95 % confidence interval does not include 1.00, this is indicated by * and bold. Excluded is indicated with Ex. The International Classification of 
Diseases is indicated by 8th revision (ICD-8), 9th revision (ICD-9) and the 10th (ICD-10). Not given is indicated by “–”
b Beane Freeman et al. (2013)
c Comprising the trachea, bronchus and lung
d Large intestine
Study NCI cohort < 1966–2004 UK cohort (1941–2012) US garment worker cohort 
(1955–2008)
Exposure (ppm) Median average intensity: 0.3 and 
range 0.01–4.3. Exposure to ≥ 1 
occurred in 15 % and 24 % had  
peak exposures at ≥ 4
Range <0.1 to >2 Geometric mean: 0.15 and geo-
metric standard deviation 1.90. 
Past exposures may have been 
about 4 ppm, see text
Risk estimatea ICD-8 O SMR ICD-9 O SMR ICD-10 O SMR
All cancers 140–209 3146b 1.07* 140–208 2241 1.10* – 1021 0.96
Solid cancers 140–199 2878b 1.09* – – – – – –
Nose and nasal sinuses 160 3b 0.90 – 2 0.71 C30–C31 0 0
Pharynx – 17 1.20 C09–C14 6 0.88
Nasopharynx 147 9b 1.84 – 1 (E: 1.7) 0.59 C11 0 0
Buccal cavity 140–149 74b 1.15 – 7 1.08 C03–C08
C46.2
6 1.42
Larynx 161 42b 1.23 – 22 1.22 C32 4 0.77
Lung 162 1130b 1.14* – 813 1.26* C33–C34c 267 1.04
Bone 170 8b 1.36 – – – –
Prostate 185 261b 1.07 – 147 0.80* – – –
Pancreas 157 111b 0.76* – 91 1.04 – – –
Breast 174 28b 0.64* – – – – – –
Hodgkin’s disease 201 25 1.42 – – – C81 4 0.95






Multiple myelomas 203 48 0.94 – 28 0.99 C88.7 23 1.24
C88.9
C90
Leukaemia 204–207 116 1.02 – 54 1.02 C91–C95 36 1.04
Ex91.4
Myeloid leukaemia 205 44 0.90 – 36 1.20 C92 21 1.28
Lymphatic leukaemia 204 36 1.15 – – – C91–C91.9
Ex 91.4
6 0.71
Stomach – – – – 182 1.29* – – –
Digestive system 150–159 759b 1.07 – 126 0.95d – – –
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leukaemia [OR (95 % CI) 11.2 (1.3–95.6)] where the refer-
ent group contained one myeloid leukaemia case who had 
never been exposed to FA. No increase was observed in the 
lymphoid malignancies, including Hodgkin’s lymphoma 
[0.5 (0.1–2.6)]. The study has severe limitations, including 
lack of exposure–response relationship within FA exposure 
groups, unstable estimates due to only one case in the refer-
ent group, or where more reliable estimates were present, 
no appropriate statistical testing was provided (WHO 2010; 
Cole et al. 2010; Golden 2011; Rhomberg et al. 2011). Due 
to these limitations, the US embalmer study is not consid-
ered a key study for risk assessment.
In the WHO (2010) evaluation, nasal cancers and lym-
phohaematopoietic malignancies were the main focus. 
Additionally, standardized mortality ratios were evalu-
ated for other types of cancer in the three comprehensive 
occupational cohorts, which have been updated recently 
(Table 3). A key approach by the WHO (2010) in the evalu-
ations of cancer effects was whether a nonlinear expo-
sure–response relationship could reasonably be identified 
with a plausible NOAEC. This approach is justified from 
the nonlinear FA–DNA adduct formation and the assump-
tion that an increase in cancer incidence would occur if the 
cellular level of FA is increased above the normal back-
ground to a level where the detoxification mechanisms 
are overwhelmed. This causes cytotoxicity and regenera-
tive cell proliferation, during which DNA lesions may be 
fixed as mutations due to a decrease of time available for 
DNA repair. Transmission from the normal homeostasis, 
determining a NOAEC, to a gradual increase in cancer 
incidence could also be expected to show a nonlinear expo-
sure response relationship. And, importantly, SCC showed 
a clear, nonlinear exposure–response relationship in rats 
(Table 2).
Portal‑of‑entry cancers in humans
Airway cancers associated with FA exposures were stud-
ied in a Finnish cohort with 1.2 million employees. All 
men born between 1906 and 1945 who were in employ-
ment during 1970 were included. The follow-up study 
was in the Finnish Cancer Register for nasal cancer (292 
cases), cancer of the nasopharynx (149 cases) and lung 
cancer (30,137 cases) during the period 1971–1995. The 
Finnish job-exposure matrix was used to estimate cumula-
tive exposures. Duration of exposure was estimated from 
census data. A latency period of 20 years was accepted. 
Number of exposed cases (N), RR obtained by comparison 
with unexposed, and 95 % confidence intervals were esti-
mated [N; RR (95 % CI)]. The RR for FA exposure was 
adjusted for smoking, socioeconomic status, and exposure 
to wood dust. The risk of nasal cancer [17; 1.1 (0.6–1.9)], 
nasal squamous cell carcinoma [9; 1.0 (0.4–2.0)] and 
nasopharyngeal cancer [5; 0.9 (0.3–2.2)] was not increased. 
The risk was slightly increased for lung cancer [1831; 1.2 
(1.1–1.3)], which was adjusted for asbestos and silica dust 
exposures. However, the risk in the highest exposure group 
(FA ≥ 1 ppm) was not increased. Thus, the authors consid-
ered the increased risk to be due to residual confounding 
effects of smoking and co-exposures, including asbestos 
and crystalline silica. FA exposures were below 1 ppm in 
most occupations. Only floor layers and men who worked 
with varnish and lacquer had average exposures at 1 ppm 
(Siew et al. 2012). Overall, this study found no increase in 
portal-of-entry cancer at low concentrations of FA in occu-
pational settings, and only a minor part of the nasal cancer 
cases were associated with FA exposures.
The US National Cancer Institute (NCI) cohort includes 
25,619 workers employed prior to 1 January 1966 in 10 
industrial plants. The cohort was followed up until 31 
December 2004 (Beane Freeman et al. 2013). At present, 
it is the second largest industrial cohort on FA exposure. 
In the cohort, 13,951 had died. The median duration of 
follow-up was 42 years, and median length of employment 
was 2.6 years. A lag time of 15 years was applied. The cal-
endar year-specific US mortality rates were used to obtain 
standardized mortality ratios (SMRs), which were stratified 
for sex, race and age. Internal exposure-dependent trends 
were obtained for the metrics, peak, average intensity and 
cumulative exposure, where the RR was set to one in the 
lowest FA exposure group. SMRs were slightly increased 
for all cancers, for solid, for respiratory system and for lung 
cancers (Table 3). For all cancers and solid cancers, the 
RR was below 1 for peak, average intensity and cumula-
tive exposure in the highest exposure groups. In the highest 
exposure group, the RR was 0.77, 1.01 and 0.79, respec-
tively, for cancer of the respiratory system. In the highest 
exposure category, lung cancer was significantly decreased 
in the peak exposure metric (RR: 0.77), unchanged in 
the average intensity metric (RR: 1.0) and significantly 
decreased in the cumulative exposure metric (RR: 0.78). 
SMRs were significantly decreased for pancreas and breast 
cancer. No increase was observed for SMRs for solid can-
cer of the buccal cavity, digestive system, liver, nose and 
nasal sinuses, larynx, bone, skin, female genital, prostate, 
bladder, kidney, and brain and central nervous system. The 
only remarkable effect was the non-significant increase 
in nasopharyngeal cancer [NPC; SMR (95 % CI) 1.84 
(0.84–3.49)]; one misclassified oropharyngeal cancer was 
included in the SMR calculations, but excluded from the 
calculation of the RRs. For NPC, the trend was only signifi-
cant in the peak exposure metric if the non-exposed group 
was excluded, and the RR was only significantly increased 
in the average intensity metric in the highest exposure 
group (Table 4). Overall, this suggests that nasopharyn-
geal cancer was the only solid cancer associated with FA 
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exposure. With regard to each metric, the middle exposure 
group had a lower RR than the non-exposed group, sug-
gesting a nonlinear exposure–response relationship with a 
NOAEC (Table 4).
The different NCI follow-up studies have been criti-
cized for not adequately addressing heterogeneity between 
plants (Marsh et al. 2007; McLaughlin and Tarone 2014; 
Marsh et al. 2014). Furthermore, the statistical evaluations 
have been criticized for instability of the referent groups 
with only one NPC case in each of the metrics, for limita-
tions in the trend test, and for the use of non-significant 
results in the interpretations (Marsh et al. 2014). The cri-
tique was further addressed by Marsh et al. (2016) in a re-
analysis of the update of the Beane Freeman et al. (2013) 
study. In the extended 10-year follow-up period, one addi-
tional NPC death was observed in the lowest exposure cat-
egory of highest peak, average intensity and cumulative FA 
exposure metrics. Repeating the calculations of the Beane 
Freeman group confirmed that the SMR was increased in 
the highest peak exposure and the highest average inten-
sity metrics. The Beane Freeman et al. study found no 
heterogeneity across the 10 plants. In contrast, the re-
analysis found a strong heterogeneity between plants in 
the FA-exposed workers with a SMR of 7.34 (95 % CI 
2.69–15.97) in one (the Wallingford) plant, but no increase 
in the other nine plants with a SMR of 0.82 (0.17–2.41). 
In the Wallingford plant, the NPC deaths were exposure 
dependent as, for example, all deaths in the peak expo-
sure metric were in the highest exposure group (≥4 ppm). 
However, a similar trend was not observed in the other 
nine plants. In general, the SMRs were higher in the unex-
posed groups than in the lowest FA exposure groups, 
used as referent groups (RR = 1) in the Beane Freeman 
et al. study. As it was considered inappropriate to omit the 
unexposed groups from the determination of exposure–
response relationships, the re-analysis used the unexposed 
as the referent groups (RR = 1). This resulted in expo-
sure–response analyses showing little or no evidence of 
associations with peak or average intensity of FA exposure 
and NPC. The authors concluded that the Beane Freeman 
et al. analysis was strongly influenced by selection of the 
referent group, not taking heterogeneity between plants 
into account and that the re-analysis provided no or little 
evidence of a persistent association between FA exposure 
and mortality from NPC.
The risk of nasal cancer, nasal squamous cell carcinoma 
and NPC was not increased in the Finnish study (Siew 
et al. 2012). There was no increase in sinonasal and NPC 
risk (SMR: 0.71) in the British cohort (Coggon et al. 2014). 
No death from NPC (1.33 expected) or sinonasal cancer 
(0.95 expected) was observed in the US NIOSH Garment 
Industry cohort (Meyers et al. 2013). The NCI case–control 
study on FA effects in the funeral industry also showed a 
low risk [OR (95 % CI) 0.1 (0.01–1.2)] of NPC (Haupt-
mann et al. 2009). Nevertheless, using the updated NCI 
cohort (Beane Freeman et al. 2013) in the risk assessment 
of portal-of-entry cancers can be considered precautionary, 
because an increase was not observed in the other com-
prehensive studies. A nonlinear exposure–response rela-
tionship can be suggested, because an increased risk was 
only seen in the highest exposure groups (Table 4); this is 
similar to the response for nasal cancer in rats that showed 
an apparent NOAEC of 2 ppm (Table 2). The new update 
confirmed that no increase in RR was seen for the peak 
exposure metric at FA <4 ppm and at the average intensity 
<1 ppm FA. This was similar to the values from the previ-
ous follow-up (Hauptmann et al. 2004) which were used in 
the WHO (2010) evaluation. Also, the values agree with a 
NOAEC for SCC in rats at 2 ppm and a lack of nasal his-
topathological effect at 1 ppm; these values were used in 
the risk characterization for preventing nasal cancers in 
humans (WHO 2010).
Table 4  Exposure-dependent 
effect of FA on development of 
nasopharyngeal cancer in the 
three formaldehyde exposure 
metrics in the US National 
Cancer Institute Cancer Cohort; 
the reference group was the 
lowest exposure category in 
each exposure metric (Beane 
Freeman et al. 2013)
The cohort comprises 25,619 workers. Number of NPC cases is indicated by N, and a significant increase 
is indicated in bold
a Not applicable (NA)
Peak exposure Average intensity Cumulative exposure
ppm RR (95 % CI) (N) ppm RR (95 % CI) (N) ppm × year RR (95 % CI) (N)
0 4.4 (0.3–54) (2) 0 6.8 (0.5–84) (2) 0 1.9 (0.3–12) (2)
>0 to <2.0 RR = 1 (1)
Reference
0.1–0.4 RR = 1 (1)
Reference
>0 to <1.5 RR = 1 (4)
Reference
2.0 to <4.0 NAa (0)
Apparent NOAEL
0.5–0.9 2.4 (0.15–39) (1)
Apparent NOAEL
1.5 to <5.5 0.86 (0.1–7.7) (1)
Apparent NOAEL
≥ 4.0 7.7 (0.9–62) (7) ≥1 12 (1.4–97) (6) ≥5.5 2.9 (0.6–13) (3)
P (trend FA groups) = 0.005 P (trend FA groups) = 0.09 P (trend FA groups) = 0.06
P (trend FA groups + con-
trols) = 0.10
P (trend FA groups + con-
trols) = 0.16
P (trend FA groups + con-
trols) = 0.07
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Laryngeal cancer
The association between laryngeal cancer and FA exposure 
was studied in a recent meta-analysis, which included six 
case–control studies [mRR (95 % CI) 1.15 (0.97–1.36)] 
and five cohort studies [1.10 (0.84–1.44)] with an overall 
mRR of 1.13 (0.98–1.31). The authors concluded that the 
meta-analysis did not support that there is an association 
between FA exposure and laryngeal cancer (Paget-Bailly 
et al. 2012). There was no increase in the risk in the three 
updated occupational cohorts (Table 3).
Lung cancer in humans
Combined data on lung cancer were constructed from 
two population-based case–control studies conducted 
in 1979–1986 and 1996–2002 in Montreal in Canada. 
A total of 2060 lung cancer cases were compared with 
2046 sex- and age-matched controls. Sociodemographic 
characteristics, lifestyle-habits (including smoking) 
and complete work history (including work tasks, work 
conditions and chemical exposures) were obtained from 
similar interview questions in the two studies. Chemical 
exposures were evaluated from exposure concentrations 
(low, medium and high), frequency of exposures (low, 
medium and high) and years of exposure. Unconditional 
logistic regression was used to estimate risks [OR (95 % 
CI)]; confounders taken into account were age, sex, 
income, number of years in school, ethnicity, smoking, 
and exposures to occupational lung carcinogens, includ-
ing asbestos and silica. About 25 % of the cases and the 
controls were exposed to FA. However, FA exposures 
were low in the majority of the subjects. For men and 
women combined, the lung cancer risk for ever- versus 
never-FA-exposed was not significantly increased [1.06 
(0.89–1.27)]. For the group of substantially exposed, the 
risk was low [0.88 (0.63–1.24)]. Moreover, a long dura-
tion of exposure (>20 years) did not increase the risk 
[0.93 (0.69–1.24)]. Similarly, no increase in risk was 
observed with age at first exposure, time since first expo-
sure, and maximum intensity of exposure. The authors 
concluded that FA exposure was not associated with 
an increased lung cancer risk, which they found was in 
agreement with majority of studies reported in the scien-
tific literature (Mahboubi et al. 2013). In the NCI cohort, 
there was no increase in lung cancer risk in the highest 
exposure category in any of the exposure metrics (Beane 
Freeman et al. 2013). Neither was an increase observed 
in the NIOSH garment cohort (Meyers et al. 2013). How-
ever, there was an increase in the UK cohort (Coggon 
et al. 2014), which was not adjusted for smoking. Over-
all, there is no consistent association between FA expo-
sure and lung cancer (IARC 2006; NRC 2014).
Cancers at distant sites
In epidemiology, a major focus has been on the association 
between FA exposure and leukaemia, especially myeloid 
leukaemia (Hauptmann et al. 2003, 2009; Beane Freeman 
et al. 2009; Schwilk et al. 2010). Of the human carcino-
gens identified by IARC, approximately 25 % induce leu-
kaemias or lymphomas. Alkylating agents, benzene, topoi-
somerase II inhibitors and ionizing radiation induce mainly 
acute myeloid leukaemia (AML). However, ethylene oxide 
and 1,3-butadiene are linked primarily with lymphoid can-
cers (Eastmond et al. 2014). The industries and occupations 
with the highest occurrence of leukaemia are not those 
with high exposures to chemicals. Thus, in the US National 
Occupational Mortality Surveillance System, the highest 
proportionality mortality ratios (PMRs) for white males 
(the largest group) are in the industries and occupations: 
bank/savings and loan/credit agency (PMR: 139–172), 
advertising/sales manager (PMR: 138–174) and electrical 
engineers (PMR: 141–192) in different periods between 
1985 and 2007 (Robinson et al. 2015).
The NCI Cohort was also followed up until 31 Decem-
ber 2004, for lymphohaematopoietic malignancies (Beane 
Freeman et al. 2009). Of the 25,619 cohort members, 4359 
were classified as never having been exposed to FA. In the 
follow-up period, 13,951 deaths occurred. The SMRs were 
calculated using the US mortality rates; they showed no 
remarkable effect of FA exposure on lymphohaematopoi-
etic malignancies (Table 3). The RR (95 % CI) for death 
from lymphohaematopoietic malignancies was examined 
for association with peak exposure, average intensity and 
cumulative exposure. The group with the lowest FA expo-
sure was selected as the referent group. There was no sig-
nificant association between cumulative exposure and any 
of the malignancies. Therefore, results are presented only 
for the peak exposure and the average intensity metrics 
(Table 5). The most remarkable increase in RR is for Hodg-
kin’s lymphoma, apparent from both metrics; this increase 
was also present in the previous follow-up (Hauptmann 
et al. 2003), but was not seen in other FA-exposed cohorts 
as mentioned by the authors. Furthermore, Hodgkin’s lym-
phoma has not previously been associated with exposures 
to chemicals (Nielsen et al. 2013; Checkoway et al. 2015); 
known risk factors are, for example, socioeconomic status, 
family size and Epstein–Barr virus infection (c.f. Nielsen 
et al. 2013). In this study, there was no significant associa-
tion with FA exposures and myeloid leukaemia (Table 3). 
In the peak exposure metrics, there was a tendency of an 
exposure-dependent increase in leukaemia (ICD-8 codes: 
204–207) as the RRs increased in the four groups from 0.59 
(0.25–1.36), 1.0 (referent group), 0.98 (0.60–1.62) to 1.42 
(0.92–2.18), respectively, with P-trend = 0.02. However, 
within the three FA groups themselves, the trend was not 
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significant (p = 0.12) and the RR in the highest exposure 
group was not significant. There was no significant relation 
between FA exposure and RRs of leukaemia in the aver-
age intensity metric, where the RR in the highest exposure 
group (≥1 ppm) was 1.10 (0.68–1.78) and P-trend >0.50. 
This is in contrast to the previous follow-up, where leukae-
mia was increased in the peak exposure metrics in the mid-
dle (2–3.9 ppm) group, RR: 2.04 (1.04–4.01), and the high 
exposed group (≥4 ppm), RR: 2.46 (1.31–4.62), with a sig-
nificant trend, and the high myeloid leukaemia group, RR: 
3.46 (1.27–9.43), also with a significant trend (Hauptmann 
et al. 2003). In the new update, the myeloid leukaemia risk 
was not increased at mean FA exposures below 1 ppm and 
peak exposures below 4 ppm. To account for the increased 
risk of Hodgkin’s disease, the mean FA concentration has 
to be below 0.5 ppm and the peak exposures below 2 ppm 
even though the disease is not considered to be caused by 
FA exposure; this is considered to be precautionary as the 
RR = 1 in the referent groups is roughly in the middle of 
the 95 % confidence limits of the non-exposed groups.
The Beane Freeman et al. (2009) study was re-analysed 
and expanded by Checkoway et al. (2015). The re-analysis 
subdivided myeloid leukaemia into acute myeloid leukae-
mia (AML) and chronic myeloid leukaemia (CML); AML 
is associated with risk factors such as tobacco smoke, 
benzene exposure, chemotherapy and ionizing radiation, 
whereas CML is associated with the Philadelphia chromo-
some, a translocation between chromosome 22 and 9, and 
with high-dose ionizing radiation. This suggests that AML 
and CML should be analysed separately. The standardized 
mortality ratio was 0.80 (95 % CI 0.56–1.14) for AML 
and 0.96 (0.56–1.67) for CML in the 22,483 FA-exposed 
workers. A further analysis was conducted in 16,306 work-
ers employed one year or more and restricted to cumu-
lative and peak exposure (which was redefined) as the 
original study showed no remarkable effect in the average 
intensity group. Cumulative FA exposures were divided 
into groups with 0 to <0.5 (referent), 0.5 to <2.5 and 
≥2.5 ppm × year and peak exposures into <2 (referent), 
≥2 to <4 and ≥4 ppm. In workers exposed for ≥1 year, 
both cumulative and peak exposures were significantly 
associated with Hodgkin’s lymphoma (confirming results 
by Beane Freeman et al. 2009) and all leukaemias com-
bined. In the middle- and high-exposure group, myeloid 
leukaemia (N; hazard ratio (95 % CI) was not increased in 
the cumulative groups [9; 1.53 (0.54–4.27) and 14; 1.58 
(0.59–4.23), respectively, with P-trend = 0.39], but was 
increased in the peak exposure groups [8; 2.49 (1.01–6.16) 
and 8; 2.03 (0.82–5.03), respectively, with P-trend = 0.08]. 
In the AML groups, risk at cumulative exposure was not 
increased [6; 1.16 (0.36–3.76) and 10; 1.31 (0.44–3.95), 
respectively, with P-trend = 0.63] and no increase was 
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(0.51–4.44), respectively, with P-trend = 0.37]. With 
regard to CML, the cumulative exposed group showed a 
non-significant increase [2; 2.91 (0.24–35.64) and 4; 3.81 
(0.36–40.44), respectively, with P-trend = 0.27], similar 
to the increase seen for the groups with peak exposure [2; 
4.83 (0.64–36.42) and 3; 5.32 (0.81–34.90), respectively, 
with P-trend = 0.07]. However, the number of deaths was 
low. In the full cohort, 13 of the 34 AML deaths were from 
the group with peak exposures of more than 2 ppm, only 
four workers had jobs with peaks within the 20 years pre-
ceding their death, and only one death occurred within 
the typical AML window of 2–15 years. Non-Hodgkin’s 
lymphoma, chronic lymphocytic leukaemia and multiple 
myeloma showed no increased risk. The authors concluded 
that the re-analysis does not support that FA causes AML, 
which they considered the most relevant leukaemia for FA 
exposure.
A follow-up from the period 1941 through December 
2012 was conducted in the British (UK) cohort from six 
factories comprising 14,008 men (Coggon et al. 2014). In 
the period, 7378 men had died. A total of 3991 of these 
men had been highly exposed to FA. In the cohort, the 
standardized mortality ratio [SMRs (95 % CI)] for all can-
cers [1.10 (1.06–1.15)], for stomach cancer [1.29 (1.11–
1.49)], for rectum cancer [1.23 (1.01–1.49)], for lung can-
cer [1.26 (1.17–1.35)] was significantly increased based on 
the national death rate for England and Wales; other values 
are given in Table 3. No significant increase was seen for 
cancer in the pharynx, larynx, nose and nasal sinuses, or for 
the different hematopoietic malignancies. Prostate cancer 
was significantly decreased [0.80 (0.68–0.94)]. The cohort 
was stratified for levels of exposure. The exposure in the 
high-exposure group was more than 2 ppm. A significant 
increase in SMR in the high-exposure group was observed 
for all cancers [1.28 (1.20–1.37)], cancer in the oesophagus 
[1.45 (1.03–1.98)], stomach [1.51 (1.18–1.90)], lungs [1.59 
(1.42–1.77)] and the lips [9.98 (1.21–36.04)]; observed/
expected: 2/0.2). No increase was seen for non-Hodgkin’s 
lymphoma [0.90 (0.48–1.55)], multiple myeloma [1.18 
(0.57–2.18)], leukaemia [0.82 (0.44–1.41)] and myeloid 
leukaemia [0.93 (0.40–1.82)]. Exposure in the high-expo-
sure group was further stratified for duration of exposure 
(<1 year, 1–14 years and ≥15 years). For oesophagus and 
lung cancer, the SMR was highest in the in the group with 
the shortest exposure (<1 year), and for stomach and rec-
tum cancer, the SMRs were independent of the length of 
the exposure period. Additionally, the authors included 
a nested case–control analysis of cancer in the upper air-
ways, larynx, mouth, pharynx, tongue, and for all leukae-
mia and myeloid leukaemia. ORs for these cancers were 
independent of the duration of the exposure. The authors 
ascribed the increases in risk estimates to non-occupational 
confounding factors, which may include smoking and 
socioeconomic factors, and they concluded that the study 
provided no evidence that FA posed an increased hazard of 
upper airway cancer or of myeloid leukaemia. It is noted 
that the study was not able to take smoking and socioeco-
nomic factors into account. Overall, the NOAEC from this 
study is approximately 2 ppm.
A new follow-up (1960–2008) was conducted of the 
US National Institute for Occupational Safety and Health 
(NIOSH) Garment Industry cohort, which is among the 
largest prospective cohorts (Meyers et al. 2013). The study 
comprised 11,043 workers. Causes of death were obtained 
from 99.7 % (3904) of the identified deaths. The year of 
first exposure was 1970 or earlier for about 77 % of the 
workers. In the early 1980s, personal FA sampling was 
performed among 549 employees. The geometric mean 
FA concentration was 0.15 ppm with a geometric stand-
ard deviation of 1.90. No exposure data were available 
before this time, but FA concentrations are believed to have 
decreased over time. Recently, NRC (2014) estimated the 
FA concentration to be about 4 ppm before 1970. Standard-
ized mortality ratios [SMRs (95 % CIs)] and internal com-
parisons were made using directly standardized rate ratios 
[SRRs (95 % CIs)] for “duration of exposure”. The SMRs 
were similar to that of the US population for all cancers, for 
lymphohaematopoietic cancers (leukaemias, Hodghin dis-
ease, non-Hodgkin’s lymphoma, and multiple myeloma), 
for buccal cavity and pharyngeal cancers, for respiratory 
cancers, and for brain cancer and other parts of the nervous 
system (Table 3).
Stratifying SMRs for “year of first exposure” (<1963, 
1963–1970, ≥1971) showed no significant increase for 
lymphohaematopoietic cancers, for trachea, bronchus and 
lung cancer, and for brain cancer and other parts of the 
nervous system. Similarly, no significant increase was 
observed for SMRs for “time since first exposure” (<10, 
10–19, ≥20 years). Association with “duration of FA expo-
sures” (<3, 3–9, ≥10 years) was studied with SMRs and 
SRRs. There was no exposure-dependent increase in risks 
for lymphohaematopoietic cancers and non-Hodgkin’s 
lymphoma. The risks increased with the length of the expo-
sures for leukaemia, myeloid leukaemia and acute myeloid 
leukaemia, but the risks were not statistically significant. 
For multiple myeloma, the SMR for the exposure groups 
was 1.2 (0.5–2.3), 2.0 (>1.0–3.6) and 0.6 (0.2–1.6), respec-
tively, and the SRR was 1.00 (reference), 1.2 (0.5–3.3) and 
0.3 (0.08 to <1.0), respectively. For trachea, bronchus and 
lung cancer, the SMR was 1.2 (>1.0–1.5), 1.1 (0.9–1.4) and 
0.7 (0.5–0.9), respectively, and the SRR 1.00 (reference), 
1.0 (0.8–1.3) and 0.7 (0.5–1.1), respectively. Thus, where 
the values were statistically significant, they were not asso-
ciated with the length of the exposure period. However, 
for individuals with ≥10 years of exposure and ≥20 years 
since first exposures, leukaemia [23 death, SMR: 1.7 
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(1.1–2.6)] was significantly increased when multiple causes 
of death were considered.
Additionally, duration of exposure was studied for leukae-
mia (36 cases) and myeloid leukaemia (21 cases) using four 
multivariate Poisson regression models (adjusted for age, 
year of birth and years since first exposure), where exposures 
either were untransformed or transformed (log, square root 
and categorical [<1.6 (reference), 1.6 to <6.5, 6.5 to <16, 16 
to <19 and ≥19 years)]. Only the untransformed model for 
leukaemia and the categorical model for myeloid leukaemia 
showed a statistically significant trend. However, for leukae-
mia and myeloid leukaemia, the rate ratios in the categori-
cal model were significantly increased in the fourth category 
[4.6 (1.3–16) and 6.4 (1.4–32), respectively], but not for the 
second, third and fifth categories; in the fifth category (expo-
sure > 19 years), no significant increase [2.6 (0.7–10) and 
1.7 (0.3–11), respectively] was observed.
The authors concluded that the study showed limited 
evidence of association between FA exposure and leukae-
mia, and little evidence of an increased risk of mortality 
from buccal cavity, pharyngeal (including nasopharyn-
geal), respiratory and brain cancer, and for Hodgkin’s dis-
ease. It is noted that the study lacks appropriate FA expo-
sure assessments and it was not able to take smoking into 
account. The importance of smoking is not clear; there 
were sporadically significantly increased values for chronic 
obstructive lung disease, but no increase in lung cancer.
Also, an Italian cohort with subjects employed in a fac-
tory producing laminate plastic, decorative papers and 
craft papers, using phenolic and melamine resins, has been 
established (Pira et al. 2014). The major risk was consid-
ered to be FA exposure, but FA concentrations were not 
measured. The cohort comprised 2750 employees from the 
period 1947 to 31 May 2011, who had been employed for 
at least 180 days. Data on survival (80.3 %), death (16.6 %, 
N = 457) and emigration (3.1 %) were obtained. Cause 
of death could not be retrieved for 26 out of 457 (5.7 %) 
deceased employees. Person-years of observation were 
70,933 in the analysis. Expected number of deaths (E) 
and SMRs were obtained by comparison with the regional 
death rates. Observed deaths (O) and SMR [O, SMR 
(95 % CI)] for lymphoma [4; 0.74 (0.20–1.90)], myeloma 
(O/E = 0/2.3), leukaemia [5; 0.92 (0.30–2.15)] and for all 
lymphohaematopoietic neoplasms [9; 0.69 (0.31–1.30)] 
were not increased. Neither was an increased risk of cancer 
observed for all cancers [149; 0.80 (0.68–0.94)]. The risk 
was non-significantly increased for oral and pharynx can-
cer [9; 1.49 (0.68–2.82)] and for bladder cancer [10; 1.51 
(0.72–2.77)]. For oesophagus, stomach, colorectal, liver, 
pancreas, larynx, lung, breast, prostate, kidney, and brain 
and CNS cancer, the SMRs were below one. The study 
has a long follow-up period, but a limitation is the lack of 
quantitative FA exposure data.
Hauptmann et al. (2009) investigated the relationship 
between mortality and work practices and FA exposure 
levels among American embalmers in a case–control study. 
Professionals employed in the American funeral indus-
try who died between 1 January 1960 and 1 January 1986 
from lymphohaematopoietic malignancies (n = 168), brain 
tumours (n = 48) or nasopharyngeal cancers (n = 4) were 
obtained for 6808 who died in the period and compared 
with deceased matched controls (n = 265) with regard to 
lifetime work practice. Exposures in the funeral industry 
were obtained by interviews with next of kin and co-work-
ers, and predictive models were used to estimate levels of 
formaldehyde exposure. Mean peak concentrations were 
8.1–10.5 ppm (model predicted as the maximum 15-min-
ute average intensity ever experienced in connection with 
embalming for all years) and the average FA intensity was 
1.5–1.8 ppm while embalming. Cases were exposed for 
about 32 years. With one myeloid leukaemia in the referent 
group, the odds ratio [OR (95 % CI)] for myeloid leukae-
mia was 11.2 (1.3–95.5) in the ever-embalming versus the 
never-embalming group. Mortality from myeloid leukaemia 
increased statistically significantly only with an increasing 
number of years of embalming (P for trend = 0.020) and 
with an increasing peak FA exposure (P for trend = 0.036). 
Within the exposure groups themselves (duration of years 
with embalming, number of embalming, cumulative FA 
exposure, average FA exposure while embalming, 8-h time-
weighted average (TWA) FA intensity and peak FA expo-
sure), there were no significant trends in any of the groups 
(P for trend = 0.58–0.97). There was no exposure-depend-
ent effect on monocytic leukaemia, polycythemia vera or 
myelofibrosis. ORs were roughly about 10 (range 5–15) in 
exposed groups. To increase stability of the risk estimates, 
subjects who performed fewer than 500 lifetime embalm-
ings were used as the referent group in a second evalua-
tion. In this analysis, the ORs for myeloid leukaemia were 
roughly about 3 (range 0.5–3.9) in the “exposed” groups. 
No true trend tests were available for this evaluation as the 
authors without explanation used the results from the trend 
tests from the first (unstable) analysis in this (more sta-
ble) analysis. However, ORs were significantly increased 
for duration of years with embalming at >20–34 years and 
>34 years, which was 3.2 (1.0–10.1) and 3.9 (1.2–12.5), 
respectively, with the highest number of embalmings 
(>3068), 3.0 (1.0–9.2), and at the highest cumulative FA 
exposure (ppm × hours: >9253), 3.1 (1.0–9.6). These expo-
sures were not related to lymphohaematopoietic malignan-
cies of the lymphoid organs (non-Hodgkin’s lymphoma, 
multiple myeloma, all lymphoma and Hodgkin’s disease), 
brain cancer or nasopharyngeal cancer [0.1 (0.01–1.2)].
The validity of the Hauptmann et al. (2009) study has 
been challenged as it relied only on RR estimates. The 
expected number of subjects with lymphohaematopoietic 
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malignancies, all myeloid leukaemias and all acute myeloid 
leukaemias were estimated from the 6808 embalmers (Cole 
et al. 2010). Comparison between the observed and the 
estimated number of subjects showed no meaningful eleva-
tion. Furthermore, the proportional mortality ratios showed 
no significant elevation. With regard to risk assessment, it 
is noted that the study does not provide convincing expo-
sure–response relationships within the different FA expo-
sure metrics, and therefore it cannot be used for setting an 
indoor air guideline level (Nielsen et al. 2013). Moreover, 
the potential hazards addressed in this study are not rele-
vant for setting an indoor air guideline level due to the very 
high exposure levels.
With regard to setting its guideline, the WHO (2010) 
used the Hauptmann et al. (2003) study as the key study 
for risk evaluation of lymphohaematopoietic malignancies. 
The new update (Beane Freeman et al. 2009) weakens the 
association between FA exposure and leukaemia and mye-
loid leukaemia, indicating that the WHO (2010) guideline 
is based on conservative estimates. Additionally, the guide-
line is set below levels associated with increase in Hodg-
kin’s lymphoma, although this disease has neither been 
consistently associated with FA exposures nor with expo-
sure to other chemicals.
Evaluation of carcinogenic risk and the WHO 
(2010) indoor air quality guideline
The two critical effects of FA are nasal cancer and irrita-
tion of eyes and upper airways (sensory irritation), where 
sensory irritation had the lowest NOAEC and is the basis 
of the WHO IAQG at 0.1 mg/m3 (0.08 ppm), applying to 
each 30-min period during each day lifelong. It is noted 
that the NOEAC for sensory irritation is 0.5 ppm and thus 
an assessment factor of 6 is used when setting the IAQG, 
which is a conservative approach. Moreover, this guideline 
value is considered to prevent all portal-of-entry effects, 
including nasal cancer, and potential systemic cancers. 
Even though the potential systemic cancer effects are con-
sidered not to be relevant with regard to setting an indoor 
guideline, all endpoints were evaluated to assure that the 
guideline level was below effect levels to ascertain a con-
tradiction-free guideline (WHO 2010; Nielsen and Wolkoff 
2010; Nielsen et al. 2013).
Cancer risk assessment of indoor air exposures to FA 
has been carried out based on two different approaches. 
One approach is linear extrapolation (e.g. Sarigian-
nis et al. 2011; Huang et al. 2013; Du et al. 2014; Rovira 
et al. 2016), which provides conservative estimates (e.g. 
Nielsen and Wolkoff 2010; Sarigiannis et al. 2011; Du et al. 
2014). As FA is an endogenous metabolite, at a certain low 
exogenous exposure level, the cellular FA level will be 
dominated by the endogenously (naturally) generated FA 
and exogenous FA contribution will be low or negligible 
(Andersen et al. 2010; Swenberg et al. 2013). Based on lev-
els of endogenous and exogenous FA–DNA adducts, it was 
shown that the linear extrapolation approach greatly over-
estimates the cancer risk (Starr and Swenberg 2013, 2016).
In 2010, the WHO launched a threshold approach for 
establishing an IAQG for FA. Analysis of cancer exposure–
response relationships in experimental animal (e.g. Table 2) 
and human epidemiological studies showed that the rela-
tionships were nonlinear (WHO 2010). Additionally, the 
mucosal metabolism would prevent systemic access of FA 
when airborne concentrations were below a few ppm FA.
With regard to experimental animal species, rats were 
the most sensitive to developing nasal cancer due to life-
long exposure with a LOAEC of 6 ppm and an apparent 
NOAEC of 2 ppm (Table 2). Nasal cancer was driven by 
cytotoxicity induced cell proliferation (Conolly et al. 2003, 
2004). This may cause DNA transcription before DNA 
lesions were repaired and thereby allow the DNA damages 
to be fixed as mutations, which in turn may cause cancer. 
The NOAEC for increased cell proliferation was >2 ppm 
(Monticello et al. 1996; Andersen et al. 2010). The his-
topathological NOAEC (1 ppm) for damage of the nasal 
epithelium was lower than the NOAEL for cell prolifera-
tion and for nasal cancer, for which reason the histopatho-
logical NOAEC was accepted as the point of departure for 
the cancer risk assessment. Also, it was accepted that the 
histopathological NOAEC was independent of the dura-
tion of the daily exposure period and therefore NOAEC 
was considered to be a full day of exposure. Furthermore, 
rats were considered more sensitive than humans. Due to 
the local airway effect, the 1 ppm level was divided by 
an interspecies assessment factor of 3 (it is noted that rats 
are a sensitive species) and an assessment factor of 2 for 
the limit variations within the human population [deposi-
tion in the upper airways is similar in children and adults, 
and the variation in the population is about 1.6-fold (Gar-
cia et al. 2009)], resulting in a guideline value of 0.17 ppm 
(0.2 mg/m3) for protection against nasal cancer. It is noted 
that the assessment factors are highly conservative. This 
approach was backed up by a comprehensive biologically 
motivated computational modelling method, predicting that 
the 80-year lifetime additional risk is ≤10−6 at 0.2 ppm 
(0.246 mg/m3) for non-smokers (Conolly et al. 2004). Pre-
venting nasal cancer was considered to prevent systemic 
cancers, including leukaemia.
The credibility of the histopathological endpoint in the 
risk assessment of cancer is further supported by recent 
animal studies. For example, the toxicokinetic studies by 
Andersen et al. (2010) showed that the local airway epi-
thelial cell FA level was not markedly affected by FA 
exposures from 0.7 to 2 ppm, and at 1 ppm, the epithelial 
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FA concentration was dominated by the endogenous 
(natural) FA concentration. At these concentrations, the 
exogenous FA–DNA adducts were lower than the endog-
enous adducts in the rat nasal tissue (Lu et al. 2010, 2011; 
Moeller et al. 2011; Edrissi et al. 2013;Yu et al. 2015). 
Moreover, the recent studies have confirmed experimen-
tally that apart from the portal of entry no absorption 
occurs in rats at exposures in the range 0.7–15 ppm (Lu 
et al. 2010, 2011; Edrissi et al. 2013; Kleinnijenhuis et al. 
2013; Yu et al. 2015) and in monkeys up 6 ppm (Moe-
ller et al. 2011). Overall, this supports the credibility of 
the selected point of departure by the WHO for low-level 
portal-of-entry effects, which if prevented also prevent 
systemic effects.
The WHO (2010) IAQG was also supported by epidemi-
ological studies. In the previous update of the NCI cohort, 
nasal cancer occurrence had a nonlinear exposure–response 
relationship where no increased risk was observed below 
1 ppm average intensity and below 4 ppm peak exposures 
(Hauptmann et al. 2004); the exposure–response relation-
ship was nonlinear. The Hauptmann et al. (2004) study was 
used as a key study by the WHO. The cohort was recently 
updated (Beane Freeman et al. 2013) with similar results. 
However, no increase in nasal cancer was observed in later 
comprehensive studies and updates (Siew et al. 2012; Mey-
ers et al. 2013; Coggon et al. 2014) and a case–control 
study (Hauptmann et al. 2009). In the latest update of the 
NCI cohort (Beane Freeman et al. 2009), myeloid leukae-
mia risk was not increased at mean FA exposures below 
1 ppm and peak exposures below 4 ppm and thus shows 
that preventing nasal cancer also prevents leukaemia. 
Remarkably, the previous follow-up study (Hauptmann 
et al. 2003) and the most recent follow-up (Beane Freeman 
et al. 2009) of the NCI cohort both showed an increase in 
Hodgkin’s lymphoma at the average intensity ≥0.5 ppm 
and peak exposures ≥2 ppm. Hodgkin’s lymphoma has not 
previously been associated with exposures to chemicals 
(Nielsen et al. 2013; Checkoway et al. 2015); known risk 
factors are, for example, socioeconomic status, family size 
and Epstein–Barr virus infection (c.f. Nielsen et al. 2013). 
Therefore, it is considered sufficient that the guideline is 
below these levels.
On the whole, the nonlinear exposure–response rela-
tionships, the epidemiological effects at levels much 
higher than the WHO IAQG and the lack of consistency 
across studies indicate that the WHO IAQG is highly 
precautionary.
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